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RANKL and Osteoprotegerin Levels in Response to Orthodontic Forces
Abstract
Orthodontic tooth movement is mediated by interactions between PDL cells and those of the alveolus.
One protein—the receptor activator nuclear factor kappa B ligand (RANKL)—is critical for
osteoclastogenesis, and osteoprotegerin (OPG) is a decoy ligand that competitively inhibits RANKL. A
higher RANKL/OPG ratio is associated with areas of bone resorption, while a lower ratio occurs in areas
of bone deposition and homeostasis. There have been almost no clinical studies of RANKL and OPG
expression in human subjects undergoing orthodontic tooth movement. The purpose of this study was to
quantify changes in the levels of RANKL and of OPG expression in human gingival crevicular fluid in
growing (adolescent) and non-growing (adult) patients in response to orthodontic force. Untreated
adolescents (under 18 years of age) and adults (over 18 years of age) had a calibrated force applied
across a left-right pair of maxillary premolars with a transpalatal spring (TPS). RANKL and OPG were
measured in gingival crevicular fluid (GCF) sampled serially from the pressure and tension sides of
maxillary premolars at 5 different time points: before placement of transpalatal spring, 1 day (24 hours)
after TPS placement, 2 days (48 hours) after TPS placement, 5 days (120 hours) after TPS placement
(TPS was then removed), and 3 days (72 hours) after TPS removal. RANKL and OPG expression was
measured by the ELISA assay. Expectations were that (1) force would raise RANKL and diminish OPG, (2)
force removal would reverse the RANKL-OPG levels, (3) strength and duration of force are associated with
RANKL-OPG levels, (4) responses would exhibit considerable inter-individual variation, (5) the RANKL/
OPG levels will be higher in children due to general growth and bone remodeling in response to
orthodontic forces, and (6) the RANKL/OPG levels will be lower in adults because no growth is occurring
and osteoclastogenesis is triggered solely by orthodontic forces. Gingival crevicular fluid (GCF) volume
increased significantly after applying force with the nickel-titanium coil spring. The volume remained
elevated until the force was removed, and had not quite returned to baseline by 3 days (72 hours)
following force removal. There were no significant differences found in the levels of GCF collected in
regards to age, sex, or race. When evaluating the changes in gingival crevicular fluid in response to
mechanical force, it appears that time is the significant factor regardless of the person’s age, sex, or race.
In general, both RANKL and OPG levels decreased significantly over the time while the spring was in
place; however, the RANKL/OPG ratio increased over time. No significant differences were found in the
levels of RANKL when comparing sex, age, and race. Higher levels of OPG were found in males. A linear
decrease in OPG was seen in regards to age; therefore, adults have less OPG than their younger
counterparts. Although not significant, African American levels of OPG were higher than Caucasians.
Further research is needed to better describe what effect variations in individual RANKL and OPG
expression have on orthodontic tooth movement.
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ABSTRACT

Orthodontic tooth movement is mediated by interactions between PDL cells and
those of the alveolus. One protein—the receptor activator nuclear factor kappa B ligand
(RANKL)—is critical for osteoclastogenesis, and osteoprotegerin (OPG) is a decoy ligand
that competitively inhibits RANKL. A higher RANKL/OPG ratio is associated with
areas of bone resorption, while a lower ratio occurs in areas of bone deposition and
homeostasis. There have been almost no clinical studies of RANKL and OPG expression
in human subjects undergoing orthodontic tooth movement.
The purpose of this study was to quantify changes in the levels of RANKL and of
OPG expression in human gingival crevicular fluid in growing (adolescent) and non‐
growing (adult) patients in response to orthodontic force. Untreated adolescents (under
18 years of age) and adults (over 18 years of age) had a calibrated force applied across a
left‐right pair of maxillary premolars with a transpalatal spring (TPS). RANKL and
OPG were measured in gingival crevicular fluid (GCF) sampled serially from the
pressure and tension sides of maxillary premolars at 5 different time points: before
placement of transpalatal spring, 1 day (24 hours) after TPS placement, 2 days (48 hours)
after TPS placement, 5 days (120 hours) after TPS placement (TPS was then removed),
and 3 days (72 hours) after TPS removal. RANKL and OPG expression was measured
by the ELISA assay. Expectations were that (1) force would raise RANKL and diminish
OPG, (2) force removal would reverse the RANKL‐OPG levels, (3) strength and duration
of force are associated with RANKL‐OPG levels, (4) responses would exhibit
considerable inter‐individual variation, (5) the RANKL/OPG levels will be higher in
children due to general growth and bone remodeling in response to orthodontic forces,
and (6) the RANKL/OPG levels will be lower in adults because no growth is occurring
and osteoclastogenesis is triggered solely by orthodontic forces.
Gingival crevicular fluid (GCF) volume increased significantly after applying
force with the nickel‐titanium coil spring. The volume remained elevated until the force
was removed, and had not quite returned to baseline by 3 days (72 hours) following
force removal. There were no significant differences found in the levels of GCF collected
in regards to age, sex, or race. When evaluating the changes in gingival crevicular fluid
in response to mechanical force, it appears that time is the significant factor regardless of
the person’s age, sex, or race. In general, both RANKL and OPG levels decreased
significantly over the time while the spring was in place; however, the RANKL/OPG
ratio increased over time. No significant differences were found in the levels of RANKL
when comparing sex, age, and race. Higher levels of OPG were found in males. A
linear decrease in OPG was seen in regards to age; therefore, adults have less OPG than
their younger counterparts. Although not significant, African American levels of OPG
were higher than Caucasians. Further research is needed to better describe what effect
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variations in individual RANKL and OPG expression have on orthodontic tooth
movement.
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CHAPTER 1.

INTRODUCTION

Bone is described as a simple tissue comprised of four major components
namely: cells, the extracellular matrix of collagen fibers, mucopolysaccharide ground
substance, and calcium salts. Although bone is a simple material, it is also dynamic and
is constantly undergoing remodeling and mineralization. Bone remodeling can be
physiological, which is the most common, pathological, or mechanical in origin. For
physiological bone remodeling to occur, a balance must be maintained between
osteoblastic (synthesis) and osteoclastic (resorption) activities. When this balance is
disturbed naturally, pathological bone remodeling will occur, leading to destructive
bone arthropies. When orthodontic (mechanical) forces are applied to a tooth, the forces
are transmitted through the periodontal ligament (PDL) and adjacent alveolar bone. The
transmitted forces ignite a chain of signal transduction events leading to a shift in the
osteoblastic/osteoclastic ratio. During orthodontic force application, areas of
compression and tension develop. On the side of the tooth where the PDL fibers are
stretched (tension), an environment forms where osteoblastic activity prevails and new
bone is formed. Areas in which the PDL fibers are under compression exhibit increased
osteoclastogenesis, with the end result being bone resorption (Masella and Meister
2006).
The culmination of events leading to orthodontic tooth movement (OTM) is
complex, and includes interaction between the alveolar bone cells and PDL cells along
with intercellular actions. The sequence of events at the tissue and cellular levels during
OTM has been thoroughly documented and is well understood. Yet, there is a lack of
knowledge surrounding the culmination of biochemical events at the molecular level in
the response to a mechanical or orthodontic force (Krishnan and Davidovitch 2006).
Recently, orthodontics has been given a new appreciation for the complexity of the
events leading to OTM through the discovery of multiple regulatory molecules and
signal transduction pathways.
Research on the molecular biology of bone has produced two osteoblast‐derived
factors that play key roles in bone growth and remodeling. The receptor activator of
nuclear factor kappa B ligand (RANKL) and osteoprotegerin (OPG) competitively bind
to their receptor, RANK. These molecules exert counterbalancing regulatory effects on
osteoclastogenesis, including osteoclast differentiation, activation, and survival, and are
as a result critical for initiation and maintenance of orthodontic tooth movement
(Kanzaki et al. 2006). The aim of the present study is to measure changes in RANKL and
OPG expression in human gingival crevicular fluid in growing (adolescent) and non‐
growing (adult) patients in response to orthodontic force.
Little is known about the levels of RANKL and OPG in human gingival
crevicular fluid (GCF), and most of the studies that have assayed GCF have been
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concerned with people with periodontitis and endodontic lesions. The purpose of this
study was to evaluate:
1)

What are the levels of RANKL and OPG in the gingival crevicular fluid in the
absence of orthodontic force? Kawasaki et al. (2006) found that the levels of RANKL
and OPG increase with age during their cross‐sectional evaluation comparing a
sample of adolescents and a sample of adults. This study assessed 54 participants
of various ages. Although there were no set age groupings for this study, in order
to treat age as a category, a number of the patients will be less than 16 years of age
or older than 30 years. Genetics appears to play a critical role in a person’s
susceptibility to external apical root resorption (Hartsfield et al. 2004). Therefore,
we are also interested in the inter‐individual variability of the sample group, since
differences in RANKL levels appear to be associated with a person’s risk for
external apical root resorption (e.g., Harris 1997; Harris et al. 2000).

2)

Transpalatal springs were placed across a pair of maxillary premolars as the
“stressor” used to stimulate RANKL production (and down‐regulate OPG
production). Several questions were addressed here. One, the mechanical force
associated with changes in RANKL‐OPG levels from the baseline at T1 (Day 0).
Expectation was that RANKL would increase and OPG would drop. Serial
sampling at 1 (T2), 2 (T3), and 5 (T4) days will provide information on whether the
sustained tension promotes sustained levels of the molecules, or whether the
responses are dynamic over time. Two, force‐removal right after T4 (Day 5) is used
to test the recovery of the system towards or, even, to the baseline levels during the
subsequent days (T4 to T5, or Days 5 to 8). It also was of interest whether the
duration‐to‐cytokine levels were simply linear or more complex in nature, and this
was assessed by fitting regression models to the data to seek maximum explained
following force degradation variance (e.g., Freund and Littell 1991). Nishijima et al.
(2006) reported that RANKL levels were significantly increased while the OPG
levels were significantly decreased at 24 hours after application of a retracting force.
The other time points he examined were zero hours, one hour, and 168 hours
(7days), which showed no significant difference in the RANKL and OPG levels.
Therefore, it can be concluded that RANKL and OPG levels return to normal.
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CHAPTER 2.

REVIEW OF THE LITERATURE

Temporal Phases of Orthodontic Tooth Movement
The typical tooth movement response after a moderate, continuous load has been
divided into three stages. The three temporal phases of tooth movement are (1) the
initial strain, (2) the lag phase, and (3) progressive tooth movement (Graber 2005; Reitan
1967). The initial strain occurs between 4 to 7 days after the initiation of mechanical
stress. This initial displacement of up to a millimeter is caused by trifold events. First,
the root is displaced into the periodontal ligament. Second, the bone is strained caused
by bending and creep, and finally, extrusion is caused by the inclined plane effect of the
tooth root pressing against the tapering alveolus (Graber 2005). The initial strain
response will differ according to the width of the PDL, root length, anatomical
configuration, force magnitude, occlusion and periodontal health. Initial tooth
displacement occurs instantaneously following mechanical loading; however, the actual
compression of the PDL requires an extended duration of force (Graber 2005).
The lag phase, which is variable in length depending on the magnitude of the
applied force, consists of undermining resorption. Undermining resorption is a process
by which bone adjacent to the areas of crushed PDL is removed (Graber 2005). The lag
phase can last from a few days up to 10 weeks depending on the density of the strained
bone (Graber 2005; Reitan 1967). During this phase, the cells in the PDL disappear due
to a loss of vascular supply, and a hyalinized (cell free) zone in the PDL appears (Proffit
2007; Reitan 1967). Remodeling of bone in areas adjacent to the necrotic tissue is
accomplished by cells derived from undamaged areas. After a small delay, cellular
elements begin to invade the hyalinized area, and undermining resorption commences.
Osteoclasts appear in the adjacent bone marrow spaces and begin to attack the
underside of bone immediately adjacent to the necrotic PDL area (Proffit 2007). During
this period, an interruption in tooth movement is expected due to (1) a delay in
stimulating cellular differentiation within the marrow spaces and (2) a significant
amount of bone must be removed from the underside of the hyalinzed zone before tooth
movement can occur. Excessive forces lead to larger hyalinzed areas, while light forces
minimize but do not eliminate undermining resorption (Graber 2005; Proffit 2007).
The final temporal phase is known as progressive tooth movement, and it is a
period of direct bone resorption that allows the tooth to continue to move (Reitan 1967).
The rate limiting step in progressive tooth movement is frontal resorption in the PDL,
and it determines the speed of orthodontic correction that can be achieved (Graber 2005).
Prostaglandin E (PGE) has both osteoclastic and osteoblastic activities; therefore, it is a
fitting mediator of tooth movement. Both osteoblasts and osteoclasts are needed for this
phase of orthodontic tooth movement. Osteoclasts arrive in areas adjacent to the
compressed PDL either from the local cell population or are brought in to the necrotic
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area via blood flow. Then, the osteoclasts attack the adjacent lamina dura and remove
bone in a process known as frontal resorption. Tooth movement begins shortly after
frontal resorption starts. Later, after the PDL is enlarged, osteoblasts, which are
recruited from local progenitor cells in the PDL, form bone on the tension side and begin
remodeling on the pressure side. See Figure 1.

Bone Metabolism and Orthodontic Tooth Movement (OTM)
Bone is a dynamic structure that is constantly undergoing remodeling and
mineralization. Bone consists of multiple cell types in an extracellular matrix of collagen
fibers, mucopolysaccharide ground substance, and calcium salts (Storey 1972). Goals of
bone remodeling include regulation of the body’s free calcium ion supply, maintenance
of the blood supply to osteocytes, which are embedded in the bone, and adaptation of
the bone to the stresses and strains of function. A balance between osteoclastic and
osteoblastic actions is absolutely necessary for physiological bone remodeling (Massella
and Meister 2006; Storey 1972).
The theories of tooth movement on the both tissue and cellular levels have
evolved dramatically over the past century. Recent discoveries deal with the nature of
tooth movement on the molecular level. According to Schwarz (1932), the first mention
of the biology of tooth movement to appear was in 1904 by Carl Stanstedt. His
investigations showed that a tooth tilts along an axis lying slightly apical to the center of
the length of the root, which allows the alveolar wall on the side under tension to
experience bone deposition, while the side under pressure experiences bone resorption.
Oppenheim (1942) published contradictory findings, theorizing that a tooth tilts at its
apex, causing transformation over a broad area on both sides of the bony alveolar wall
due to both the compression and tension combined. Schwarz (1932) explained the
differences between Stanstedt’s and Oppenheim’s findings by stating that Oppenheim
did not see the acute effect of the applied force because he sacrificed his experimental
animals several days after the appliance had last been activated.
Storey (1972) discussed three different biologic systems for the movement of
teeth. These are the bioelastic phenomena, bioplastic adaptive behavior, and
biodisruptive deformation of tissues. Magnitude of force and frequency of application
determine whether the tooth moves within its socket or is translated through the bone.
The support system of teeth includes the interstitial fluid, the periodontal ligament
(PDL), and the viscoelastic properties of the ligament (Henneman et al. 2008). Forces
exceeding the bioelastic limit result in changes in the connective tissues and vascular
system, which leads to adaptive proliferation and remodeling of the tissues. Forces that
exceed the bioplastic limit result in biodisruptive deformation, leading to interference in
nutrition, ischemia, inflammation, rupture of connective tissues, and localized cell death.
Orthodontic forces that are absorbed by the PDL and adjacent alveolar bone are

4

Figure 1. The three phases of tooth movement: (1) initial strain; (2) variable lag
phase; and (3) progressive tooth movement.
After application of a moderate orthodontic load (0.2 to 0.5 n, or about 20 to 50 g), tooth
displacement can be divided into three phases: (1) initial strain for 1 to 3 days in the
periodontal ligament (PDL) and supporting bone; (2) a variable lag phase, in which
undermining resorption removes bone adjacent to crushed areas in the PDL; and (3)
progressive tooth movement through frontal resorption in the PDL limits the rate of
orthodontic tooth correction (Graber 2005).
Source: Reprinted with permission. Graber TM, Vanarsdall RL, Vig KWL, editors.
Orthodontics. Current Principles and Techniques, 4th Edition. St Louis: Mosby Elsevier
2005.
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therapeutic when they lie between the bioelastic and bioplastic limits. When force
exceeds the bioplastic range, tooth movement occurs more slowly. Even heavier forces
cause tooth movement to cease due to compression of the connective tissue on the
pressure side being compressed into the bone. Regardless of the amount of force, the
inflammatory process is limited to the periodontal tissue and does not extend beyond
the bone that supports the teeth. The tissue involved in orthodontic tooth movement
acts like a viscoelastic material, and consequently strain in the PDL is related to time (i.e.,
length of force application) and to stress (Storey 1952; Storey 1972).
Application of orthodontic forces on a tooth will cause a shift in osteoblastic and
osteoclastic dynamics. On the side of the tooth where the PDL fibers are being stretched
(the tension side) an osteoblastic environment is formed, where the osteoblasts enlarge
and multiply and new bone is formed. Conversely, on the side under pressure, a
process of undermining resorption is initiated due to the tooth compressing the
periodontal tissues against the bony socket. The compression side exhibits
osteoclastogenesis, which leads to increased activity of osteocytes and bone resorption
(Massella and Meister 2006; Storey 1972). Bone resorption does not occur along the
pressure side until the cell‐free area has been eliminated by undermining resorption. A
hyalinized zone is produced by light forces, so the underlying bone is readily removed
by resorption (Reitan 1967). Eventually, new bone formation occurs in the direction of
the applied force in the form of projecting trabeculae on the periosteal aspect of the
alveolar plate (Meikle 2006; Roberts et al. 1981; Stanstedt 1904).
As established by Roberts, Goodwin, and Heiner (1981), bone remodeling in
response to orthodontic force can be divided into three major categories: (1) turnover, in
response to accumulation of microfractures; (2) reorientation of bone mass to optimally
resist stress; and (3) net change in volume related to functional load. This can be
simplified as an activation, resorption, and formation (ARF) sequence at the tissue level.
The critical factors at the cellular level of tooth movement include the distribution of
stress, displacement of the PDL, and bone deformation. Cell perturbation, bioelectrical
signals, microenvironmental factors and accumulation of microfractures have all been
considered as causative to the biophysical events in the cellular response to tooth
movement. It has been discovered that mechanical strain activates multiple cell
signaling pathways (Meikle 2006). During orthodontic tooth movement, the
inflammatory pathway is activated via phospholipase A2 that causes the release of
arachidonic acid followed by the synthesis of prostaglandin E2 (PGE2). The increase in
PGE2 activates adentylate cyclase that causes a brief increase in intracellular cAMP. The
increased intracellular cAMP then causes an increase in intracellular calcium and the
stimulation of DNA synthesis (Meikle 2006). To provide further evidence that
prostaglandins are involved in orthodontic tooth movement, the use of cyclooxygenase‐
1 inhibitors (COX‐1) have been linked to decreased tooth movement (Harrell et al. 1977;
Yamasaki et al. 1980). Another metabolite of arachidonic acid is leukotriene, which is
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produced by the lipoxygenase pathway, is a potent stimulator of bone resorption
(Meikle 2006).
Two other signaling pathways have been identified in the mechanical force
transduction. First, mechanical force causes an activation of the cAMP messenger
system. cAMP and cGMP are secondary messengers associated with bone remodeling,
and they are mediated through the phosphorylation of certain substrate proteins by
their dependent protein kinases (Krishnan and Davidovitch 2006). At first, the
application of mechanical force causes a decrease in cAMP levels and an increase of
calcium uptake into the cells. Shortly thereafter, cAMP levels rise, and bone remodeling
activities commence (Meikle 2006). Lastly, the phosphoinositide pathway (PIP) is
activated by prostoglandin E2, and parathyroid hormone (PTH), and the pathways’ by‐
products cause a release of intracellular calcium. This pathway is responsible for the
elevation of intracellular calcium via the endoplasmic reticulum and increased DNA
synthesis (Krishnan and Davidovitch 2006; Meikle 2006). As technology improved, it
was discovered that these signaling pathways lie downstream of the initial
mechanoreceptor event, which causes the stimulation of specialized proteins, known as
cytokines, to initiate the process of bone remodeling.

Molecular Elements Involved in OTM
In the early stages of OTM, the fluid in the periodontal ligament (PDL) cells is
shifted, therefore causing strain on both the PDL and ECM. Applied mechanical forces
are transduced from the strained extracellular matrix (ECM) to the cytoskeleton through
cell surface proteins. This mechano‐transduction occurs by ECM binding to cell
adhesion molecules, known as integrins, and other cell surface receptors (Krishnan and
Davidovitch 2005). The areas where the integrin receptors physically link actin‐
associated cytoskeletal proteins with the ECM and with adhesion molecules on adjacent
cell surfaces are called focal adhesions. Integrin‐mediated adhesive interactions play a
key role in cell migration, proliferation and differentiation, but they also regulate
intracellular signal transduction pathways. As such, integrins function as both cell
adhesion molecules and intracellular signaling receptors (Meikle 2006). The strain
produced by the mechanical forces stimulates a chain of events that plays a key role in
the movement of teeth. First, there is a change in the shape of the cells in the ECM, and
this elicits the release of signaling molecules from the affected cells. Due to the tension
or compression of orthodontic forces, the nerve terminals of the ECM cells become
distorted and release vasoactive neurotransmitters. Since the nerve terminals in the PDL
cells are located near blood vessel walls, the neurotransmitters immediately recruit
circulating leukocytes through diapedesis. Then, the leukocytes emit signaling
molecules, including growth factors, colony‐stimulating factors and cytokines, therefore
causing an inflammatory response stimulating the remodeling of the PDL and alveolar
bone cells (Krishnan and Davidovitch 2005). Substance P, an enkephalinic
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neurotransmitter, also is released causing vasodilation, increased vascular permeability,
and some analgesia. Greater forces will cause decreased release of substance P,
therefore causing more discomfort to the patient (Parris et al. 1989).

Cytokines
Cytokines are low‐weight extracellular signaling proteins produced by cells that
control the action of other cells in a paracrine or autocrine fashion. They have various
roles in the body, such as mediating the immunological response of the host to
exogenous antigens, and both physiological and stress‐induced bony metabolism. These
proteins are produced by fibroblasts, osteoblasts, and other connective tissue cells
(Meikle 2006). The secretion of these proteins is generated by various stimuli, including
neurotransmitters, bacterial products, other cytokines, and mechanical forces (Krishnan
and Davidovitch 2005). Cytokines are divided into groups according to their functions
and include interleukins (IL), tumor necrosis factor (TNF), interferons (IFN), growth
factors (GF), and colony‐stimulating factors (CSF). Systemic hormones and mechanical
stimuli, such as the forces generated in orthodontic tooth movement, influences bone
metabolism by their ability to control the synthesis and action of cytokines (Meikle
2006). The cytokines that affect bone metabolism via orthodontic forces during OTM
include interleukin 1 (IL‐1), interleukin 2 (IL‐2), interleukin 3 (IL‐3), interleukin 6 (IL‐6),
interleukin 8 (IL‐8), tumor necrosis factor alpha (TNFα), gamma interferon (IFNγ), and
osteoclast differentiation factor (ODF) (Krishnan and Davidovitch 2005).
IL‐1 is the most potent stimulator of osteoclast function, and it serves as a bone
resorptive agent. The interleukins attract leukocytes, and stimulate target cells such as
fibroblasts, endothelial cells, osteoclasts, and osteoblasts. The main role of the
interleukins is to promote bone resorption and inhibit bone formation. Another pro‐
inflammatory cytokine, TNFα, induces both acute and chronic inflammation, and
promotes bone resorption, while inhibiting bone formation. TNFα promotes
osteoclastogenesis in tandem with its inflammatory response (Krishnan and
Davidovitch 2009). IFNγ, a strong inducer of major histocompatibility antigens in
macrophages, promotes the synthesis of cytokines, such as IL‐1 and TNFα. IFNγ also
encourages bone resorption by apoptosis of effector‐T cells (Krishnan and Davidovitch
2005; Meikle 2006).

Osteoclasts and Osteoblasts
Two major groups of cells control the body’s bony metabolism. Osteoclasts and
osteoblasts have equal but opposite functions during normal bone remodeling and
skeletal homeostasis (Horowitz et al. 2001). However, in metabolic disease or extreme
skeletal stresses and strains, the osteoblast to osteoclast ratio is altered, and the affected
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area enters a state either of predominant bone resorption (i.e., osteoporosis) or
deposition (i.e., osteopetrosis).
Osteoblasts are produced locally by the proliferation and differentiation of
periodontal ligament fibroblast‐like cells (Roberts et al. 1981). Therefore, osteoblasts are
mesenchymal in origin, since they differentiate from mesenchymal stem cells through a
series of progenitor stages, and finally form mature, matrix secreting osteoblasts
(Horowitz et al. 2001). The main role of osteoblasts is to secrete bone extracellular matrix
proteins that will become mineralized to form functional, strong, and mechanically
sound bone. In addition to bone deposition, osteoblasts secrete matrix
metalloproteinases (MMPs) to degrade the non‐mineralized layer of osteoid prior to
bone resorption. Without the removal of this organic layer, osteoclasts are unable to
attach to the bone’s surface to initiate bone resorption (Henneman et al. 2008).
Conversely, osteoclasts remove bone structure. These multi‐nucleated giant cells
are found only in bone and exclusively remove calcified structures (Suda et al. 1999).
Specifically, osteoclasts are located on endosteal bone surfaces and the periosteal
surfaces beneath the periosteum (Arai et al. 1999). Osteoclasts are hematopoietic in
origin, and are strongly associated with macrophages (Horowitz et al. 2001). Bone
resorption, whether it physiological or in response to external stimuli (e.g., orthodontic
force), is accomplished by the osteoclast binding to the bone surface and forming a zone
sealed from the extracellular environment. Then, the osteoclast forms a resorption
lacuna as a consequence of secreting proteolytic enzymes into the space between the
bone and the osteoclast plasma membrane (Horowitz et al. 2001). The proteolytic
enzymes remove the osteoid of the bone leaving the mineral content of bone exposed.
Subsequently, the osteoclast uses a unique organelle, known as the ruffled border, to
pump hydrogen ions (H+) into the lacuna to dissolve the mineral component of the bone
(Horowitz et al. 2001). In addition, the collagenous component of bone is destroyed by
lysosomal cysteine proteinases and cathepsins, which are also secreted by the osteoclast
(Sasaki 2003). Mature active osteoclasts are characterized by a high expression of
markers, such as tartrate resistant alkaline phophatase (TRAP), cathespin K, calcitonin,
and vitronectin receptors (Boyle et al. 2003; Feige 2001).
In the customary bone remodeling cycle, osteoclastic bone resorption proceeds
osteoblastic bone formation. Therefore, osteoclasts are recruited to a specific site via cell
signaling, adhere to the bone, and promote resorption. In opposition, osteoblasts
identify the areas of resorption by an unidentified means, travel to the affected sites and
repair the deficiency by secreting bone extracellular matrix (i.e., osteoid). The coupling
action of these two cells maintains the equilibrium of bony skeleton (Horowitz et al.
2001). In regards to the directed, external forces used in OTM, osteoclastic bone
resorption is essential, for the reason that the supporting alveolar bone must be removed
from the pressure side of the tooth’s PDL for tooth movement to occur (Masella and
Meister 2006; Oshiro et al. 2003; Roberts et al. 1981). However, on the stretched side of
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the PDL, osteoblastic bone formation must occur to keep the tooth well supported in the
alveolar bone (Henneman et al. 2008; Masella and Meister 2006).

Osteoclast Differentiation and Activation
Osteoclastogenesis is a complex progression of events that requires intimate
contact between the PDL cells (fibroblasts) and bone cells (osteocytes and osteoblasts) to
form fully activated osteoclasts (Boyle et al. 2003; Henneman et al. 2008; Ikeda et al. 2000).
The osteoclast is a tissue‐specific macrophage polykaryon created by the differentiation
of monocyte/macrophage precursor cells at or near the bone surface (Boyle et al. 2003).
First in the presence of the cytokine M‐CSF (macrophage – colony stimulating factor) the
hematopoietic precursor cells, are stimulated to differentiate into pre‐osteoclasts. Then,
soluble factors produced by osteoblasts and fibroblasts aid in the further differentiation
of pre‐osteoclasts to mature osteoclasts (Boyle et al. 2003; Henneman et al. 2008).
Mediators produced by fibroblasts and osteoblasts include M‐CSF, receptor activator of
nuclear kappa β ligand (RANKL), osteoprotegerin (OPG), and bone morphogenic
proteins (BMPs) (Henneman et al. 2008). According to Arai et al. (1999), pre‐osteoclasts
can differentiate into osteoclasts in the presence of both M‐CSF and RANKL, however in
the presence of M‐CSF only, they differentiate into macrophages. Cell‐to‐cell contact
between stromal cells and osteoblasts expressing RANKL allow several pre‐osteoclasts
to fuse together to form a polykaryon, or multi‐nucleated giant cell (Boyle et al. 2003). In
the final step of osteoclastogenesis, the polykaryon attaches to the bone via specific
integrins, and is stimulated by osteopontin (OPN) to complete differentiation
(Henneman et al. 2008). Characteristically, osteoclasts show a high level of cell adhesion,
and their growth and differentiation are anchorage dependent (Arai et al. 1999). As a
result, an osteoclast does not become fully activated, or mature, until attached to bone.
A mature osteoclast is capable of resorbing mineralized tissue, as well as producing
enzymes to resorb the fibrous components of bone (Boyle et al. 2003; Henneman et al.
2008). The life span of an osteoclast is related to the duration of a positive stimulus. The
osteoclast will remain active as long as positive stimulus is present (expression of
RANKL or IL‐1 by osteoblast/stromal cells). When down‐regulation of RANKL or up‐
regulation of OPG occurs (e.g., the stimulus is removed), osteoclasts will quickly
experience apoptosis (Feige 2001; Suda et al. 1999). TNF‐α presents another pathway of
osteoclastogenesis, which is present in inflammatory bone resorption. Together with
IL‐1, TNF‐α‐induced osteoclasts are thought to play a role in the bone resorption seen in
inflammatory bone resorption (Ikeda et al. 2001). Therefore, there are two pathways of
osteoclastogenesis: the RANKL‐pathway and the TNF‐α pathway.
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RANK, RANKL, and OPG
Both osteoblast and osteoclast differentiation and cellular activities are regulated
by a variety of molecules, including (1) osteotropic hormones and cytokines, (2)
inflammatory mediators, and (3) growth factors (Meikle 2006). The knowledge
surrounding osteoclast differentiation and activation has been expanded upon by the
modern analysis of the tumor necrosis factor (TNF) and TNF‐like proteins, such as
receptor activator of the nuclear factor – κβ (RANK), RANK ligand (RANKL), and
osteoprotegerin (OPG) (Boyle et al. 2003; Leibbrandt and Penninger 2008).
The receptor activator of the nuclear factor kappa β ligand (RANKL), a TNF
family member, is a membrane‐bound protein that is expressed on osteoblasts, stromal
cells, and other cell types (Feige 2001; Horowitz et al. 2001; Lacey et al. 1998). RANKL
mRNA is expressed in many cell types throughout the body, including chondrocytes in
developing bone and the periosteum of mature bone. The highest expressions of
RANKL are seen in skeletal and primary and secondary lymphoid tissue (Leibbrandt
and Penninger 2008). RANKL expression is increased by parathyroid hormone (PTH),
1α25‐(OH)2 Vitamin D3, dexamethasone, IL‐1, IL‐11, oncostatin M, and PGE2, although it
is decreased by TGF‐β (Horowitz et al. 2001).
Three isoforms of RANKL have been identified, named RANKL 1, RANKL 2,
and RANKL 3. Each isoform is unique, yet all can mediate osteoclastogenesis. The
originally discovered isoform, RANKL 1, is implicated in the roles of survival and
activation of dendritic cells or T‐cells and as a factor of osteoclastogenesis (Ikeda et al.
2001; Liebbrandt and Penninger 2008). Both RANKL 1 and RANKL 2 have
transmembrane domains, but RANKL 2 has a shorter intracellular domain and is
regulated by a different promoter than the other two isoforms. The soluble isoform,
RANKL 3, does not have a transmembrane domain or intracellular domain and appears
to be produced physiologically. The extracellular domains of all three isoforms are
essentially identical and capable of binding to two different receptors, known as RANK
and OPG, both of which are TNF‐related receptor proteins. RANK was isolated from
dendritic cells, while OPG was isolated as a protein inhibiting bone resorption (Ikeda et
al. 2001). A study by Leibbrandt and Penninger (2008) stated that the membrane‐bound
RANKL isoforms induce osteoclastogenesis more efficiently than the soluble RANKL
isoform.
RANKL, via intercellular signaling, has a potent effect on osteoclast
differentiation from hematopoietic precursor cells, and it stimulates osteoclast bone
resorptive activity (Burgess et al. 1999; Udagawa et al. 1999). Binding of RANKL to an
osteoclast RANK site results in the activation of signaling pathways leading to the
intracellular expression of several TNF receptor associated factors (TRAF’s) (Boyle et al.
2003; Wise and King 2008). TRAF6 acts as a key adaptor to assemble signaling proteins
for the NF‐Kβ pathway, which directs osteoclast‐specific gene expression leading to
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differentiation and activation (Boyle et al. 2003). Therefore, a TRAF6 deficiency will lead
to osteopetrosis (Boyle et al. 2003; Burgess et al. 1999). The survival of the mature
osteoclast depends on the presence of RANKL (IL‐1 and M‐CSF also promote osteoclast
survival). Nevertheless, without it the osteoclasts quickly undergo apoptosis (Feige
2001; Suda et al. 1999). Another key regulator in osteoclastogenesis is M‐CSF, a product
of the stromal cells. In the presence of RANKL, M‐CSF can stimulate the differentiation
of osteoclasts from hematopoietic precursors and activate mature osteoclasts. Without
RANKL, M‐CSF cannot cause osteoclast differentiation, therefore causing the precursors
to develop into macrophages (Arai et al. 1999; Burgess et al. 1999). M‐CSF plays three
roles in osteoclastogenesis: (A) it induces RANK; (B) it is a competence factor for
differentiation; and (C) it stimulates cell survival and proliferation. As a result, RANKL
is the differentiation factor for osteoclasts, but it is not an exclusive osteoclast
commitment factor due to its expression in osteoclasts, dendritic cells, and T‐cells (Arai
et al. 1999).
On the other hand, OPG is a novel soluble member of the tumor necrosis factor
receptor superfamily, which has profound inhibitory effects on osteoclast differentiation
and bone resorption (Burgess et al 1999). The term osteoprotegerin literally means
protector of bone, and it was the first molecule of the trio to be discovered by virtue of
its ability to inhibit osteoclast development in vitro and in vivo (Liebbrandt and
Penninger 2008). OPG, also known as osteoclast inhibitory factor, is found in the body
only as a soluble decoy receptor, because it lacks a membrane‐spanning domain (Feige
2001; Suda et al. 1999). In order to become active, the initial osteoprotegerin protein
must cleave the amino acid signal peptide to become the mature functional peptide
(Liebbrandt and Penninger 2009). Binding of OPG to the RANK site of preosteoclasts
competitively inhibits the binding of RANKL, which terminates their differentiation into
mature osteoclasts (Kanzaki et al. 2005). OPG is found in high concentrations in
developing bone, and its expression is increased by bone morphogenetic protein (BMP),
IL‐1, TNF, TGFβ, and estrogen. Conversely, its production is inhibited by PGE2,
glucocorticoids, 1,25(OH)2 vitamin D3 and PTH (Horowitz et al 2001). Although OPG
expression is typically found near areas of bone, it has also been found in vessel walls,
and it may be responsible for maintaining large vessel viability. More importantly, OPG
may regulate pericytes, which are responsible for the life‐threatening osteoblastic‐like
calcification in the walls of blood vessels (Horowitz et al. 2001). OPG mRNA expression
has also been found in the brain, liver, lung, heart, kidney, skeletal muscle, skin,
intestines, calvaria, stomach, testis and placenta (Liebbrandt and Penninger 2008,
Liebbrandt and Penninger 2009).
When added to bone marrow cultures, OPG reversibly inhibits
osteoclastogenesis (Yasuda et al. 1998). For example, in mice treated with 10 mg/kg OPG
intravenously all osteoclasts disappear within 48 hours (Feige 2001). However, within
the next 7 to 10 days, osteoclasts return and can be found in normal numbers and in
typical locations in these OPG‐treated mice (Lacey et al. 1998). Given that treatment with
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OPG reduces the number of osteoclasts and reversibly inhibits RANKL binding, it has
been suggested that it could be used in the treatment of bone arthropathies, such as
osteoporosis, crippling arthritis, and osteopenic disorders (Liebbrandt and Penninger
2008, Liebbrandt and Penninger 2009). A recent study determined that bone resorption
modulated by RANKL and OPG not only stimulated osteoclast differentiation, but also
affected changes in osteoblast proliferation, which is highly suggestive of a feedback
mechanism from osteoclasts to osteoblasts (Lin et al. 2007).
RANK, or the receptor activator of NF‐κB, is the functional receptor for both
RANKL and OPG (Horowitz et al. 2001). RANK is a member of the TNF receptor
superfamily, and it encodes for type I transmembrane glycoproteins that has four parts
including a signal peptide, an extracellular domain, a transmembrane domain, and a
cytoplasmic domain (Horowitz et al. 2001; Liebbrandt and Penninger 2008, Liebbrandt
and Penninger 2009). Both RANK and OPG molecules competitively bind to RANKL,
thereby inducing either bone resorption or bone deposition, respectively. Expression of
RANKL and OPG is therefore coordinated to regulate bone resorption and density
positively and negatively by controlling the activation state of RANK on osteoclasts
(Boyle et al. 2003). Since RANK is a TNF receptor, it is assumed that RANK
trimerization is a prerequisite for RANKL binding and signal transmission. RANK
mRNA is most abundant in dendritic cells, bone, skeletal muscle, thymus, liver, colon,
small intestine, and the adrenal gland, but RANK protein can also be detected on the
surface of dendritic cells, CD4+ and CD8+ T‐cells, Langerhans cells, or on mammary
epithelial cells where expression is regulated throughout pregnancy (Horowitz et al.
2001; Liebbrandt and Penninger 2008, Liebbrandt and Penninger 2009) (Figure 2).
Osteoclast differentiation and function appear to be regulated by a
counterbalancing system, which has been referred to as the RANKL/RANK/OPG
regulatory axis (Boyle et al. 2003). The RANKL/OPG regulatory system is controlled by
the regulation of specific gene expression, and serves the purpose of maintaining bone
structure and function, as well as meeting the body’s physiological needs for ions
sequestered in bone (Figure 3). An increased RANKL/OPG ratio will favor osteoclast
formation and activation, so bone resorption will occur. In contrast, a decreased
RANKL/OPG ratio promotes bone formation by inhibiting osteoclastic activity (Kanzaki
et al. 2001). Tight control over the body’s RANKL/OPG regulatory axis must be
maintained in order to keep bone remodeling in homeostasis (Boyle et al. 2003). For
example, over‐expression of OPG or treatment with recombinant OPG has shown an
increase in bone density and osteopetrosis in mice. However, ablation of OPG
expression showed early onset osteoporosis. On the other hand, mice with inactivated
RANKL expression developed severe osteopetrosis and showed defective tooth eruption
resulting from a complete lack of osteoclasts, while over‐expression of RANKL led to
osteoporosis (Feige 2001; Leibbrandt and Penninger 2008, Leibbrandt and Penninger
2009). These findings unambiguously establish the pivotal role of RANKL‐RANK
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Figure 2. RANKL and OPG interactions on RANK in osteoclast development.
The progenitors of stromal cells and osteoblasts are mesenchymal stem cells (MSC).
After exposure to bone morphogenic proteins (BMPs), a MSC will differentiate into an
osteoblast or a stromal cell. However, exposure to certain antagonistic proteins like
Noggin impedes the differentiation process. Committed stromal cells and osteoblasts
express RANKL on their cell surface. RANKL is regulated by a variety of molecules
including 1,25(OH)2D3, PTH, M‐CSF, and gp130‐receptor cytokines (such as IL‐6 and
Oncostatin M). RANKL interacts with its receptor, RANK, which is expressed on
hematopoietic osteoclastic precursor cells. Interaction between RANKL and its receptor
RANK induces terminal differentiation of these cells into mature bone resorbing
osteoclasts, therefore promoting bone resorption. Conversely, OPG, also known as a
decoy receptor, inhibits the RANKL‐RANK interaction by binding to RANKL.
OPG‐RANKL binding terminates osteoclastogenesis and promotes bone deposition.
M‐CSF plays a vital role in osteoclast differentiation, but cannot fully activate mature
osteoclasts without the presence of RANKL. Soluble M‐CSF, secreted by stromal cells or
osteoblasts, interacts with its receptor c‐fms to support and enhance osteoclastogenesis.
In addition, stromal cells and osteoblasts also express M‐CSF on their cell surface. It has
yet to be determined whether this form of M‐CSF is active in osteoclast formation.
(Horowitz et al. 2001).
Source: Reprinted with permission. Horowitz MC, Yougen X, Wilson K, Kacena MA.
Control of osteoclastogenesis and bone resorption by members of the TNF family of
receptors and ligands. Cytokine Growth Factor Rev 2001;12:9‐18.
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Figure 3. The balance between RANKL and OPG controls osteoclast activity.
Feige (2001) and others suggest that most inducers of bone resorption—and of
hypercalcemia—act through the RANKL‐OPG axis.
Source: Reprinted with permission. Feige U. Osteoprotegerin. Ann Rheum Dis
2001;60:81‐4.
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interactions in positively regulating osteoclastogenesis, counteracted and balanced by
OPG, which functions as a natural decoy receptor for RANKL (Boyle et al. 2003;
Liebbrandt and Penninger 2008). In effect, all factors that either inhibit or enhance bone
resorption by osteoclasts also positively or negatively influences RANKL and OPG
mRNA/protein levels. Therefore, the complex process of osteoclast‐mediated bone
remodeling converges at the RANKL/RANK/OPG axis (Liebbrandt and Penninger 2008).
The essential function of this regulatory axis in osteoclastogenesis, and bone remodeling
also is relevant to human bone diseases. New, promising drugs targeting RANKL and
OPG are being developed for the treatment of bone arthropies (Liebbrandt and
Penninger 2009).

Functions and Dysfunctions of the RANKL/OPG Regulatory Axis

Tooth Eruption and Development
Several local signaling molecules have been discovered around the developing
tooth bud, however RANKL, RANK, and OPG have been found at significant levels in
these areas (Liu et al. 2005). At times of increased osteoclastic activity, the RANKL/OPG
ratio is increased in one of two ways: (1) down‐regulation of OPG by CSF‐1; or (2) by
up‐regulation of RANKL by a number of osteogenic cytokines such as TNF‐α, IL‐1α,
TGF‐β1, and CSF‐1. Studies of RANKL knockout mice have shown that absence of
RANKL leads to failed tooth eruption, even when given a RANKL transgene, suggesting
that the RANKL needed to initiate and sustain alveolar bone resorption is produced by
the dental follicle (Liu et al. 2005). RANKL is expressed primarily in the coronal part of
the dental follicle, while OPG is thought to predominate in the apical portion, favoring
bone formation (Harokopakis‐Hajishengallis 2007).
Ohazama et al. (2004) also examined OPG, RANK, and RANKL gene expression
during tooth development in mice. Gene expression was analyzed in explant cultures
from epithelial thickening to cytodifferentiation stages. OPG is weakly expressed in the
initial thickening of tooth epithelium, as well as in the outer edges of the mesenchyme
during the bud stage. RANKL and OPG are both strongly expressed in the internal and
external enamel epithelium throughout the cap stage. When RANKL signaling is
temporarily inhibited during tooth development by administration of exogenous OPG,
adverse effects are observed. Tooth development is delayed, resulting in thin dentin
and enamel and narrower pulp tissue. This suggests that the RANKL signaling system
plays an integral role in tooth development, and disruption or dysfunction of the
RANKL/OPG axis can have serious negative consequences.
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Primary Tooth Root Resorption
In order for tooth eruption or orthodontic tooth movement to occur, two
requirements must be met. First, both of these processes require a soft tissue, such as the
PDL, that intervenes between the tooth structure and the alveolar bone. This soft tissue
plays an important role in regulating the remodeling of the adjacent tissues. Second,
both require bone turnover that is temporarily and spatially regulated to facilitate
specific translocations of teeth through the alveolar bone (Wise and King 2008).
Tooth eruption is a fundamental developmental and physiological process, while
force plays a secondary role. Resorption of the primary tooth root is a requisite for the
proper eruption and emergence profile of its permanent successor (Wise and King 2008).
The bilateral consistency and symmetry regarding the exfoliation of primary teeth and
the eruption of permanent teeth suggest that these occurrences are coupled and
genetically programmed events. The pressure of the erupting tooth has been reported as
the initial contributory action in the chain of events leading to primary tooth exfoliation
(Sahara 2001). However, a permanent successor is not mandatory, because the roots of
primary teeth without a permanent successor will eventually resorb as well. The
eruption and exfoliation process is regulated by the endocrine system and the
nutritional intake of the individual (Harokopakis‐Hajishengallis 2007); therefore these
factors have an indirect effect on the resorption course of the primary root. Conditions
such as hypothyroidism, pituitary dwarfism, and chronic malnutrition will usually
delay the shedding of primary teeth, and these conditions can interfere with the
eruption of permanent teeth (Harokopakis‐Hajishengallis 2007).
Root resorption of the primary teeth starts at the site of the root closest to its
permanent successor. Root resorption is initiated and regulated by the stellate reticulum
and the dental follicle of the underlying permanent tooth via the secretion of stimulatory
molecules (Harokopakis‐Hajishengallis 2007). Molecularly, the root resorption process
is similar to bone remodeling, involving many of the same transcription factors and
cytokines. Release of RANKL from a tooth’s dental sac seems integral to the dissolution
of bone occlusal to the permanent tooth and, thus, bone resorption is a rate‐limiting
factor in tooth eruption (at least during the preemergent phase) (Tyrovola et al. 2008).
Likewise, RANKL from the succedaneous tooth’s dental sac activates odontoclasts,
leading to root resorption and the subsequent exfoliation of the primary predecessor
(Harokopakis‐Hajishengallis 2007; Tyrovola et al. 2008). Odontoclasts are responsible for
the resorption of dental hard tissue. Compared to osteoclasts, odontoclasts are smaller
in size, have fewer nuclei, and produce smaller resorption lacunae. The metabolic and
enzymatic properties of odontoclasts are also similar to osteoclasts (Harokopakis‐
Hajishengallis 2007; Tyrovola et al. 2008; Yildirim et al. 2008). RANKL and CSF‐1 have
been found in much higher concentrations than OPG during in vivo studies of the dental
pulp of exfoliated primary teeth, which also might contribute to primary tooth root
resorption and exfoliation (Yildirim et al. 2008).
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External Apical Root Resorption (EARR)
External apical root resorption is an unavoidable pathologic consequence of
orthodontic tooth movement. EARR is defined as an iatrogenic disorder that occurs,
unpredictably and most commonly during orthodontic treatment, whereby the resorbed
apical root portion is replaced with normal bone (Yamaguchi et al. 2006). EARR is a
complex, sterile inflammatory process; however certain risk factors increase an
individual’s likelihood of developing this condition. Individual susceptibility, genetics,
and systemic factors are risk factors for developing EARR (Harris et al. 1997; Yamaguchi
et al. 2006), while sex and age during treatment do not predispose a person to an
increased risk of EARR (Harris 2000; Hartsfield, Everett and Al‐Qawasmi 2004). Other
predictors for EARR include: short blunted roots, irregular root form, trauma, tooth
devitalization with or without endodontic therapy, ectopic eruption, traumatic
occlusion, heavy mastication and bruxism, and oral habits such as tongue thrusting and
nail‐biting (Harris 2000; Hartsfield, Everett and Al‐Qawasmi 2004; Parker and Harris
1998). The movement of teeth with mature roots, extensive root movement, and
intrusive mechanics have been reported to increase the risk of EARR (Parker and Harris
1998).
Variations in RANKL and OPG expression play an important role in root
resorption (Boyle et al. 2003). Odontoclasts and cementoblasts share similar regulatory
pathways with osteoblasts and osteoclasts (Oka et al. 2007; Sasaki 2003), so there is
reason to suppose that increased expression of RANKL is associated with severe root
resorption (Al‐Qawasmi et al. 2006). In a rat study model by Low et al. (2005), increased
expression of RANKL was seen in the presence of root resorption induced by heavy
orthodontic forces. Compressed PDL cells extracted from patients exhibiting severe root
resorption expressed significantly more RANKL and significantly less OPG compared to
patients exhibiting normal root resorption (Yamaguchi et al. 2006). This suggests that
the compressed PDL cells in cases of severe EARR may produce large amounts of
RANKL, and therefore up‐regulate osteoclastogenesis (Tyrovola et al. 2008). It has been
suggested that up to 90% of individual variation in observed root resorption can be
attributed to types of mechanics (e.g., intrusion, lingual root torque) (Harris et al. 1997),
but individual variation in RANKL/OPG expression may also result in variations in
observed clinical root resorption. Moreover, individual responses to specific vectors
(e.g., intrusion, lingual root torque) are themselves modulated by the person’s genotype
(Hartsfield et al. 2004).

Bone Metabolism Dysfunction
The RANKL/OPG system is responsible for regulating a wide variety of
biological and physiological processes, many with major health‐care ramifications.
Dysfunction resulting from alterations in the RANKL/OPG ratio accounts for a number
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of abnormalities in bone dynamics. For instance, if the ratio of RANKL to OPG is
increased (by either an over‐expression of RANKL or a deficiency of OPG), osteoclastic
resorption of bone will predominate over osteoid deposition by osteoblasts, and
osteoporosis will develop (Sasaki 2003). Pharmacological companies and researchers
alike are trying to develop new treatments and medications aimed at inhibiting RANKL
mediated activation of osteoclasts by OPG. In theory, these new treatment regimens
would be an effective method of treating the symptoms of osteoporosis, and may also
lessen the amount of cartilage destruction seen in arthritis (Anandarajah 2009; Jones et al.
2002; Liebbrandt and Penninger 2007; Vega et al. 2007). In contrast, mice with a RANKL
deficiency or OPG over‐expression exhibit osteopetrosis, defects in tooth eruption, and
few osteoclasts due to the inability of osteoblasts to initiate osteoclastogenesis through
RANKL/RANK signaling (Kong et al. 1999). In the disease process of multiple myeloma,
RANKL is up‐regulated in the bone marrow microenvironment. It has also been
observed that myeloma cells express RANKL and inhibit OPG expression, leading to
osteoporosis, lytic bone lesions, hypercalcemia, and increased risk of bone fractures
accompanied by severe bone pain (Leenheer 2004). Alterations in the RANKL/OPG
ratio are also observed in the pathological process of Paget’s disease (Rifkin and Gay
1992). Interestingly, the RANKL‐OPG axis has been implicated in the slowed wound
healing seen in type II diabetics, chronic heart disease (including calcifications of the
blood vessels), and rheumatoid arthritis (Jones et al. 2002; Vega et al. 2007;). Recently,
serum OPG levels have been used as a potential indicator in the diagnosis of certain
disease processes; such as prostate cancer (marked increase in serum OPG levels),
multiple myeloma (lower than normal concentrations of serum OPG), breast cancer
(increased serum OPG levels may increase the tumor cell survival by inhibiting
TRAIL‐induced apoptosis), and renal disease (decreased serum OPG levels) (Vega et al.
2007). Therefore, it is clear that the RANKL/OPG system is responsible for regulating
many biological processes and that preventing or correcting alterations in the system
could help alleviate the symptoms of a number of pathological conditions.

Periodontitis in Smokers
Periodontitis is a chronic inflammatory disease that is caused by an infection of
anaerobic, gram‐negative bacteria (Buduneli et al. 2008; Lappin et al. 2007). The bacteria
colonize in the subgingival area, and they cause localized and systemic elevations of
pro‐inflammatory cytokines (Buduneli et al. 2008). The increase in inflammatory
mediators results in tissue destruction leading to gingival inflammation, attachment
loss, bone loss, and eventually tooth loss if left untreated (Tang et al. 2009). The function
of osteoclasts, which cause resorption of alveolar bone in periodontal disease, is
regulated by interaction with periodontal ligament cells. The periodontal ligament
fibroblasts appear to be involved in both stimulatory and inhibitory processes.
However, gingival fibroblasts have been shown to produce higher levels of OPG and
may have a greater protective effect than the periodontal ligament fibroblasts (Lappin et
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al. 2007). Overall, bone resorption will occur in periodontitis as the result of the
uncoupled process in bone remodeling, and it is usually reflected in an increased
RANKL/OPG ratio. The increased ratio is either due to an increase in RANKL, a
decrease in OPG, or a combination of both (Tang et al. 2009). Patients with diagnosed
periodontitis have been reported to have an increase in RANKL and a decrease in OPG
in both the gingival tissues and in gingival crevicular fluid. As a consequence,
RANKL/OPG ratios are found to be increased in periodontitis patients when compared
to healthy controls (Buduneli et al. 2008; Lappin et al. 2007; Tang et al. 2009).
One of the major risk factors for chronic periodontitis is smoking, which modifies
the periodontal response to microbial challenge (Buduneli et al. 2008). A clear dose‐
response relationship between periodontitis and smoking has been reported in several
studies (Tang et al. 2009). The relative risk of developing periodontitis increases by up to
six times in smokers (Lappin et al. 2007; Tang et al. 2009). The periodontal pathogens for
both smokers and non‐smokers are similar; so the accentuated loss of alveolar bony
support in smokers must be caused by nicotine actions on the body (Buduneli et al.
2008). Recently, several studies have investigated the link between RANKL and OPG
and increased bone loss in smokers versus non‐smokers with periodontal disease.
Cigarette smokers tend to have lower serum concentration of OPG, which affects the
RANKL/OPG ratio in a manner that lends itself to bony resorption. The increased bone
loss seen in smoker‐related periodontitis may be partially explained by suppression of
OPG production (Buduneli et al. 2008; Lappin et al. 2007; Tang et al. 2009).

Gingival Crevicular Fluid
Gingival crevicular fluid (GCF) arises from the gingival plexus of blood vessels
in the gingival corium, subjacent to the epithelium lining the dentogingival space
(Alfano 1974). Components found within the GCF originate from the blood, host
tissues, and subgingival plaque (Delima and Van Dyke 2003). The molecules isolated
from the sulcular fluid include: electrolytes, small organic molecules, proteins,
cytokines, specific antibodies, bacterial antigens, and enzymes of both host and bacterial
origin (Carranza and Newman 1996; Delima and Van Dyke 2003). Gingival crevicular
fluid contains several cell population such as; bacteria from the adjacent plaque mass,
desquamated epithelial cells, and transmigrating leukocytes, and sometimes
erythrocytes. However, red blood cells are an incidental finding, and they are indicative
of injury to the microvasculature and inflammation (Delima and Van Dyke 2003).
When first discovered, crevicular fluid was considered a continuous transudate
(Brill 1969), but it is currently considered an inflammatory exudate (Carranza and
Newman 1996). In healthy gingival tissue, negligible amount s of GCF can be collected
(Carranza and Newman 1996; Delima and Van Dyke 2003). Inflammatory conditions,
such as gingivitis and periodontal disease, will increase the presence of the
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inflammatory exudate by more than 5‐fold (Kowashi et al. 1980). Nearly half of the cells
in the sulcular fluid are leukocytes, thus the major route of entry into the oral cavity for
these cells is by way of the gingival sulcus. These inflammatory cells persistently
emigrate from the peripheral blood stream into the gingival sulcus due to chemotactic
factors initiated by inflammation (Delima and Van Dyke 2003).
Orthodontic forces produce an environment that can be described as “a
continuous sequence of inflammation and repair designed to restore normal tissue
continuity and function” (Meikle 2006). As opposed to the inflammation observed in
response to periodontal disease, this inflammation is aseptic, but the reaction involves
many of the same cytokines because orthodontic tooth movement results from a
combination of both pathologic and physiologic responses (Wise and King 2008).
Iwasaki et al. (2005) measured changes in IL‐1β and IL‐1 receptor antagonist (IL‐1RA)
expression in human crevicular fluid in response to orthodontic tooth movement.

Obtaining RANKL and OPG from Crevicular Fluid
Gingival crevicular fluid can be collected from the gingival sulcus with minimal
patient discomfort; however, the obstacle in obtaining the fluid is the relative shortage of
it in the sulcus (Carranza and Newman 1996). The most common collection method
includes the use of absorbent paper strips. Paper strips are placed into the sulcus until
resistance is encountered. Proper placement of the paper strip is essential, because
excess force during placement can cause irritation of the epithelium, which can trigger
the discharge of a surplus of crevicular fluid (Carranza and Newman 1996). According
to Löe and Holm‐Pederson (1965), in order minimize the induced irritation; the paper
strip should be placed immediately adjacent to the entrance of the sulcus.
As discussed in research in periodontology, RANKL and OPG are both present
in gingival crevicular fluid, and they can be readily obtained clinically (Bostanci et al.
2007; Mogi et al. 2004). Consequently, these studies indicated that GCF samples can be
collected noninvasively and longitudinally across time in the same subjects. Studies
show that GCF containing measurable amounts RANKL and OPG can be obtained from
the sulcus of teeth subjected to orthodontic forces (Heinrich et al. 2005; Kawasaki et al.
2006; Nishijima et al. 2006).
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CHAPTER 3.

MATERIALS AND METHODS

Patient Selection
In regards to RANKL and OPG levels in the gingival crevicular fluid (GCF), little
knowledge seems to be available describing the variations according to age, race, and
sex. In this study, 54 subjects were used to explore the possible differences between sex
and age (Table 1). However a number of the participants were still undergoing growth
and development, while another sample of the participants were only experiencing the
static changes of bony remodeling associated with adulthood. The literature suggests
that the decrease in the amount of tooth movement with age may be associated with a
decrease in the RANKL/OPG ratio during the early stages of orthodontic tooth
movement. The transition into adulthood induces a shift in the expression of RANKL
and OPG that favors osteoclast formation, and it has been reported in humans that OPG
levels decrease significantly with ageing (Tyrovola et al. 2008). An effort was made to
achieve a proportionate number of males and females in both groups in this study. As is
common, the recruitment of females in this study was greater than that of males. To
evaluate the potential difference in RANKL and OPG production between races, subjects
were identified either as white of European extraction or African American. An effort
was made to obtain equal numbers of American whites and African American
participants, but, due to the demographics of the patient pool in the school and the
geographical location of the study, there were a slightly greater number of African
Americans than American whites.
To minimize the variability of RANKL and OPG in the gingival crevicular fluid
(GCF), there were several exclusion criteria. Subjects did not (1) have a remarkable
medical history for a systemic disease; (2) did not have active periodontal disease or
previous treatment for periodontal disease; (3) did not have acute gingival
inflammation; (4) did not have untreated decay; (5) did not have any endodontic lesions;
(6) did not have trauma from occlusion; (7) were not currently using any form of
NSAIDS; and (8) were not currently using bisphosphonates. A recent study by Menezes

Table 1.

Sample sizes by age, and race among the 54 participants in the study.

Age

n

Male

Female

Caucasian

African American

Child

26

18

8

11

15

Adult

28

8

20

13

15

Total

54

26

28

24

30
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et al. (2008) showed that RANKL/OPG levels are affected by the development of
periapical granulomas, which is the reasoning behind omitting subjects with
radiographic pulpal disease. According to the Menezes study, radiolucencies smaller
than 5 mm had a higher RANKL/OPG ratio than those with larger bony defects, which
was indicative of the stable or progressive nature of the lesion. Previous studies on the
cytokine levels in the GCF have described an increased ratio of RANKL to OPG during
periodontal disease leading to bone loss (Bostanci et al. 2007), so subjects with active or
previous periodontal disease were omitted from participation. NSAIDS are anti‐
inflammatory pharmacological substances that inhibit prostaglandin production. These
inhibited prostaglandins are responsible for up‐regulation of osteoclastic activities.
Since NSAIDS eliminate the production of critical inflammatory cytokines, their use in
orthodontics causes a noticeable reduction in clinical tooth movement (Arias and
Marquez‐Orozco 2006). Therefore, since the use of NSAIDS affects the RANKL to OPG
ratio, potential subjects using these agents were not allowed to participate in the study.
Acetaminophen is notably the only common analgesic that has been shown not to
adversely affect the inflammatory process leading to clinical tooth movement (Roch et al.
1997). The positive pain relieving effect achieved by acetaminophen coupled with the
lack of interference of prostaglandin synthesis may make this drug ideal for the
discomfort experienced during orthodontic treatment.
Similarly, clodronate, a non‐n‐containing bisphosphonate has been shown to
reduce tooth movement in rats by inhibiting the stress‐induced gene expression of
COX‐2, which reduced the production of prostaglandin E2 and RANKL (Liu et al. 2006)
Although not all of the bisphosphonate class of drugs has been studied in regards to the
RANKL and OPG ratio, individuals using any bisphosphonate drug were not allowed to
participate in the study due to potential interaction with the specific cytokines being
examined.
No substantial data can be found to determine the needed sample size to
distinguish a difference in sexual dimorphism. Therefore, a subjective sample size of 54
subjects was used with 26 of the subjects being male and the remaining 28 being female.
This arbitrary number surpasses the number of rats or humans used in previous
experimental studies, and it is within the confines of the cost, time, and effort that can be
expended during this study.
The study was HIPPA compliant, and IRB approval was provided before the
study began (IRB # 08‐08807‐XP). The subjects were selected through an open
enrollment process at the University of Tennessee, Department of Orthodontics. The
majority of participants was either employees of the dental school or was selected from
various screening appointments for comprehensive orthodontics. The subjects obtained
from screening appointments were not required to begin comprehensive treatment
during the research period. The accompanying parent or caregiver of the screened
adolescent was also offered the opportunity to be a participant in this study, given that
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the adult patient pool at the University of Tennessee is small. Many of the parents and
siblings of the screened individuals accepted the offer to join the study. All subjects
were recruited between June and November of 2010.

Orthodontic Force Model
After patient recruitment and obtaining informed consent, each patient had a
transpalatal spring with constant force placed across their maxillary arch. The spring
was ligated to buccally‐bonded fixed retainers on the maxillary first and second
premolars (Figure 4). The orthodontic force model was placed with the following
protocol:
1) The buccal surfaces of both maxillary first and second premolars were pumiced to
remove any debris that could interfere with the bonding process.
2) The premolars were rinsed and air‐dried. The teeth were isolated from saliva
contamination by cheek retractors and cotton rolls.
3) The buccal surfaces of the four maxillary premolars were etched with 37%
phosphoric acid gel for 60 seconds.
4) Each tooth was rinsed for a minimum of 10 seconds to ensure the complete removal
of all the etchant.
5) The premolars were again air‐dried, and fresh cotton rolls were placed to keep the
teeth isolated from saliva contamination.

Figure 4. Occlusal and right and left lateral views of the nickel titanium transpalatal
spring.
A transpalatal spring was attached bilaterally to bonded retainers on the maxillary
premolars to allow a force of 150‐250 grams to be exerted on the teeth.
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6) The buccal surface of each premolar was then coated with a thin layer of TransBond
XT® bonding primer. The primer was light‐cured for 5 seconds on each tooth.
7) A sufficient amount of TransBond XT® adhesive paste was applied to the buccal
surface of each tooth.
8) The fixed retainer was placed on top of the adhesive paste, and carefully situated in
place below the height of contour of each tooth.
9) Excess adhesive paste was removed, and a small amount of bonding primer was
rubbed over the surface of the fixed retainer and adhesive paste interface to ensure a
smooth surface.
10) The adhesive paste on each tooth was light‐cured for a minimum of 20 seconds.
11) Following the bonding procedures, the cheek retractors and cotton rolls were
removed and the transpalatal spring was placed.
12) The transpalatal spring was held in place by 0.010” steel ligatures running under
the contacts and through the embrasures of the adjacent premolars. The ligatures
were securely ligated to the fixed retainers on the buccal surfaces of the premolars.
A spring gauge was used to measure the initial loading of the spring, and the force
placed upon the teeth was checked at each time interval while the spring was in
place.
13) Each patient was given orthodontic wax to help minimize the discomfort of the
appliances and to increase the likelihood of completion of the experiment.
14) Following the fourth sample collection, the appliance was completely removed.
Any remaining adhesive was removed, and the buccal surfaces of the premolars
were polished with a standard prophy paste.

Gingival Crevicular Fluid Sampling Protocol
Gingival crevicular fluid was sampled from both the pressure and the tension
surfaces. Collection of samples separately from these two surfaces of the stressed
premolars allows testing of the RANKL and OPG levels to determine if the
concentrations are reversed during the opposing conditions (Garlet et al. 2008). Samples
were stored at ‐20° C for later processing. The samples were collected at the following
time intervals (Figure 5):
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Figure 5. Schematic showing of the time‐line of the experiment.
Each box is 1 day, with a total of 8 days.

1)

A baseline sample was collected prior to the placement of any orthodontic
appliance (T1). A transpalatal spring (TPS) was placed after sampling. Following
the protocol of Parris et al. (1989), a spring gauge was used to measure the initial
tension load of the TPS (in the range of 150 to 250 gm).

2)

One day (24 hours) after TPS placement (T2). A spring gauge was used to re‐set the
tension of the TPS to that measured for the patient at T1 as needed.

3)

Two days (48 hours) after TPS placement (T3). Tension of the TPS was re‐set to that
patient’s T1 value.

4)

Five days (120 hours) after TPS placement (T4). Spring tension was measured, and
then the spring was removed after collecting the sample.

5)

Three days (72 hours) after TPS removal, which was 8 days after the baseline
sample (T5). No orthodontic treatment began until after the experimental period
was concluded; this included spacers, bands, and brackets.

Sampling and Processing Preparation
1)

At each reading, all clinically detectable supragingival plaque was removed from
the maxillary first premolars without touching the gingival tissue to prevent plaque
contamination. It was necessary not to touch the gingiva to prevent blood
contamination.

2)

Saliva contamination was prevented by cotton roll isolation. The tooth also was
also air‐dried to aid in prevention of saliva contamination.
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3)

A paper collection strip (PerioPaper strips – Oraflow Inc., Smithtown, NY, product #
593520) was inserted 1 mm into the gingival sulcus on the pressure and separately
on the tension sides (Figure 6).

4)

If any strips were noted to be contaminated with blood upon removal, they were
discarded.

5)

The Periotron® (Oraflow Inc.) was used to measure the amount of gingival crevicular
fluid collected from each site. The Periotron reading from each paper strip was
converted to μL via of the formulations published by Chapple et al. (1995).

6)

The paper strips were combined together into (4 from the pressure sides and 4 from
the tension sides) one 1.5 mL centrifuge tube containing 200 μL phosphate buffered
saline (PBS, pH 7.2) and protease inhibitors: 0.1 mM
phenylmethylsulphonylfluoride and 5 μg/mL each of leupeptin, pepstatin,
amastatin, chemostatin, and antipain (made from Protease Single‐Use Cocktail by
Thermo Fisher Scientific, Inc., Waltham, MA). The sample extraction was allowed
to take place for 2 hours at 4° C prior to re‐freezing the samples.

7)

The samples were stored at ‐20° C for later processing.

8)

The samples were then thawed and gently shaken for 1 minute. The tubes were
then centrifuged at 2000X g for 1 minute at 4° C.

Figure 6. Insertion of the perio paper 1 mm into the sulcus.
The perio paper was inserted into the sulcus and remained in place for 60 seconds to
absorb the highest possible volumes of GCF.
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9)

The volume of sample collected was recorded and additional buffer was added to
each sample to dilute the total sample volume to 200μL. Since different amounts of
buffer were added to each sample, the dilution factor was calculated for every
sample to allow accurate calculation of RANKL and OPG concentrations.

10) The samples were then processed with enzyme‐linked immunosorbent assays
(ELISA) kits for RANKL (PeproTech, Rocky Hill, NJ # 900‐K142) and OPG (R & D
Systems Inc., Minneapolis, MN # DY805 ) analysis.

RANKL ELISA Processing
1)

100 μL of capture antibody were added to each ELISA plate well. The plate was
sealed and allowed to incubate overnight at room temperature.

2)

The plate was washed four times with wash buffer and inverted on a paper towel to
allow the residual wash buffer to drain our of the individuals wells. Excess wash
buffer was removed by blotting the plate against dry paper towels.

3)

300 μL of block buffer were added to each ELISA plate well. The block buffer was
allowed to incubate for a minimum of an hour at room temperature.

4)

Another wash cycle was completed following the block buffer incubation (see
above #2).

5)

Standards were prepared according to normal dilution. 50 μL of both the standards
and samples were added to each well in duplicate. Triplicates were not used
during this study due to the small amount of GCF collected. Minimal amounts of
the extraction buffer were added to each sample in order to decrease the likelihood
of over‐dilution; and therefore, a negligible ELISA reading.

6)

After a 2 hour incubation period for the standards and samples, another wash cycle
was completed (see above #2).

7)

50 μL of detection antibody were added to each ELISA plate well. The detection
antibody was allowed to incubate for two hours.

8)

Another wash cycle was completed following the detection antibody (see above #2).

9)

50 μL of avidin peroxidase was added to each ELISA plate well. The avidin
peroxidase was allowed to incubate for 30 minutes. During this incubation period,
the ELISA plate was placed in drawer to prevent the sunlight from interfering with
the occurring reaction.
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10)

Another wash cycle was completed following the incubation of the avidin
peroxidase (see above #2).

11)

The ABTS substrate liquid was allowed to warm to room temperature prior to use.
Then, 50 μL of avidin peroxidase was added to each ELISA plate well. The plate
was allowed to incubate in a drawer, and it was monitored for color development
of color.

12)

The plate was read by an ELISA plate reader set a wavelength of 405 nm. The
plate was read at 10 minutes, 20 minutes, and 30 minutes to determine the best fit
of the standard curve.

13)

Both the 4‐parameter and the log/log‐X curves were analyzed to determine the best
fit for the assay. The 4‐parameter graph was determined to have the best standard
curve for the RANKL assay.

OPG ELISA Processing
1)

100 μL of capture antibody were added to each ELISA plate well. The plate was
sealed and allowed to incubate overnight at room temperature.

2)

The plate was washed three times with wash buffer and inverted on a paper towel
to allow the residual wash buffer to drain out of the individuals wells. Excess wash
buffer was removed by blotting the plate against dry paper towels.

3)

300 μL of reagent diluent were added to each ELISA plate well. The reagent diluent
was allowed to incubate for a minimum of an hour at room temperature.

4)

Another wash cycle was completed following the reagent diluent incubation (see
above #2).

5)

Standards were prepared according to normal dilution. 50 μL of both the standards
and samples were added to each well in duplicate. Triplicates were not used
during this study due to the small amount of GCF collected. Minimal amounts of
the extraction buffer were added to each sample in order to decrease the likelihood
of over‐dilution; and therefore, a negligible ELISA reading.

6)

After a 2 hour incubation period for the standards and samples, another wash cycle
was completed (see above #2).

7)

50 μL of detection antibody were added to each ELISA plate well. The detection
antibody was allowed to incubate for two hours.
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8)

Another wash cycle was completed following the detection antibody (see above #2).

9)

50 μL of a working dilution of Streptavidin‐HRP was added to each ELISA plate
well. The Streptavidin‐HRP was allowed to incubate for 20 minutes. During this
incubation period, the ELISA plate was placed in drawer to prevent the sunlight
from interfering with the occurring reaction.

10)

Another wash cycle was completed following the incubation of the
Streptavidin‐HRP (see above #2).

11)

50 μL of substrate solution were added to each ELISA plate well. The substrate
solution was allowed to incubate for 20 minutes. During this incubation period,
the ELISA plate was placed in a drawer to prevent the sunlight from interfering
with the color development.

12)

25 μL of stop solution were added to each ELISA plate well. The plate was gently
tapped following the addition of the stop solution to ensure thorough mixing.

13)

The plate was immediately read by an ELISA plate reader set a wavelength of 450
nm.

14)

Both the 4‐parameter and the log/log‐X curves were analyzed to determine the best
fit for the assay. The log/log‐X graph was determined to have the best standard
curve for the OPG assay.

Five subjects voluntarily withdrew from study due to patient compliance issues.
These participants either could not physically or emotionally keep the orthodontic force
model in place for the required time period. The initial samples collected from these
subjects were used to determine the appropriate dilution factors and standard analysis
procedures for the RANKL and OPG assays.

Statistical Analysis
During this protocol, the same individuals were followed over a period of time
(i.e., a longitudinal study). A longitudinal study is the strongest of all research
protocols; as a result a repeated‐measures design can be used that is efficient for
detecting differences if they truly exist. The correct variance‐covariance matrix
calculations are available using the SAS statistical packaged. Tests were evaluated as
two‐tail t‐tests at the conventional alpha level of 0.05.
Statistically speaking, the primary question was whether the level of RANKL
and/or OPG changes within individuals of different age groups over time given the
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protocol of (1) inducing mechanical stress on the PDL and adjacent bone and then (2)
removing the mechanical stress and testing for a recovery of the RANKL/OPG ratio to
baseline levels. The basic statistical model was the analysis of covariance, or ANCOVA.
Prior studies suggest that there is considerable inter‐individual variability and that the
distributions may not be normal because of outliers (e.g., Hamman et al. 2010; Stutzmann
and Petrovic 1984; Stutzmann and Petrovic 1989). Our two‐fold expected solution was
(1) to log‐normalize the data (e.g., Sokal and Rohlf 1995) so the effect of outliers is
diminished and (2), in complementary analyses, use simpler nonparametric statistics to
test for differences across time (e.g., Siegel and Castellan 1998). Patient’s age, sex, and
race were evaluated as covariates, but we did not expect sex to contribute significantly
to the observed variance. It is wholly unknown whether force of the TPS (in the range of
150 to 250 gm) would provide a discernible dose‐response effect; we are unaware of any
study that has tested for this. Inclusion of a range of tensional forces will allow us to test
for a relationship using the ANCOVA model (with force and force² as covariates).
Alternatively, we also used age, sex, force and force‐duration as potential predictor
variables in a stepwise logistic model (Freund and Littell 1991), but interpretation was
the same as with the ANCOVA model.
We analyzed two outcome variables, namely the level of RANKL and that of
OPG, because the titers of these two molecules are not tied together in any deterministic
fashion. On the other hand, it seemed conventional in the literature to rely on the ratio
of RANK‐to‐OPG, so changes in this proportionality also will be evaluated.
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CHAPTER 4.

RESULTS

Tooth Movement Model
The research protocol used here is detailed in the prior chapter. In brief, a
transpalatal spring was anchored to pairs of left and right premolars across the palate
were used to induce tooth movement over a five day period (Figure 4). Springs were
tied via steel ligatures to bonded wires near the necks of the teeth, but not interfering
with the gingiva. A force of 150 to 250 mg was placed over the four premolars during
the loading of the spring. The spring was left in place and its load re‐evaluated at each
reading until its removal. With this model, there is a considerable tipping force, with
the crown (above the center of resistance) being pulled lingually, and the root apices
tipping buccally. In concept, the lingual portions of the tooth’s sulcus would
accumulate fluid of the adjacent regions of the PDL that are under compression, while
the buccal portions would accumulate fluid from regions under tension. It is not evident
how much mixing and flow of fluid occurs around the tooth’s circumference, but four
quadrants of the sulcus were sampled separately in order to test for possible differences
(Figure 7).

Gingival Crevicular Fluid
Gingival crevicular fluid (GCF) normally accumulates from the gingival plexus
of blood vessels in the gingival corium between the crevice of the attached gingiva and
the tooth. The gingival corium lies subjacent to the epithelium lining the dentogingival
space (Alfano 1974). Stress on the tooth, notably mechanical stress, up‐regulates fluid
expression (Meikle 2006; Wise and King 2008). These increases in response to
mechanical stress are evident in Figure 8, which is a plot of the four lingual
(compression) sites, and Figure 9, which is a plot of the four buccal (tension) sites.
The gingival crevice around the periphery of a tooth is continuous, so there
should be mixing (and fluid homogenization) among the specific collection sites. The
fluid volumes measured at all five examinations were summed to examine the
correlation matrix of volumes (Table 2). All of the correlations were positive, and based
on the sample size of 270 (and overlooking covariations among examinations), those
correlations above r = 0.13 are statistically significant at alpha of 0.05. Correlations are
low (ca. r ≈ 0.20), suggesting a good deal of independence in fluid volumes around the
crevicular circumference of the premolars.
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Figure 7. Schematic of the occlusal view of the maxillary right premolars.
Crevicular fluid samples were obtained at each examination on a designated
buccal and lingual location per tooth, mesiobuccal (MB), mesiolingual (ML),
distobuccal (DB), and distolingual (DL). The same samples were collected from
the two teeth in the left quadrant (not shown), and the left and right samples were
combined for analysis. Eight paper strips were collected at each examination.
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Figure 8. Plot of the amounts of crevicular fluid in the lingual quadrants of the
crevice as a function of time.
The five examinations are scaled along the X axis. (T1 = day 0; T2 = day 1; T3 = day
2; T4 = day 5; T5 = day 8). Abbreviations are first premolar (tooth 4) and second
premolar (5), left (Lt) and right (Rt), plus mesiolingual (ML), and distolingual (DL).
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Figure 9. Plot of the amounts of crevicular fluid in the buccal quadrants of the
crevice as a function of time.
The five examinations are scaled along the X axis. Abbreviations are first premolar
(tooth 4) and second premolar (5), left (Lt) and right (Rt), plus mesiobuccal (MB), and
distobuccal (DB).
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Table 2. Matrix of correlations (n = 270) among the eight collection sites based on
combining the crevicular fluid volumes at the five examinations.
Sites
R 4MB
R 5MB
L 4DB
L 5DB
R 4ML
R 5ML L 4DL
L 5DL1
R 4MB 1.000
0.370
0.131
0.179
0.122
0.159
0.138
0.262
R 5MB 0.370
1.000
0.211
0.243
0.031
0.179
0.215
0.142
L 4DB
0.131
0.211
1.000
0.170
0.159
0.101
0.144
0.108
L 5DB
0.179
0.243
0.170
1.000
0.062
0.191
0.215
0.147
0.031
0.159
0.062
1.000
0.190
0.209
0.200
R 4ML 0.122
R 5ML 0.159
0.179
0.101
0.191
0.190
1.000
0.317
0.284
L 4DL
0.138
0.215
0.144
0.215
0.209
0.317
1.000
0.353
0.142
0.108
0.147
0.200
0.284
0.353
1.000
L 5DL
0.262
1The values of the five examinations were combined for these calculations. Values
significant at (P < 0.05) in the lower‐left half of the matrix are shown in bold and
underlined. Abbreviations are left (L) and right (R) sides of the arch and mesiobuccal
(MB), distobuccal (DB), mesiolingual (ML), and distolingual (DL) sites of fluid collection.
The premolars are number as first (4) and second (5) premolar using Palmer notation.
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Crevicular Fluid Side Differences
Analysis of the individual collection sites seemed unwarranted because of
individual variability, but the sums of the buccal (tension) and lingual (compression)
sides of the teeth were compared. Table 3 (Figure 10) lists the results of paired t‐tests at
each of the five examinations. Of note, there was a statistically significant difference at
each comparison, with the lingual volumes consistently greater than on the buccal sites.
The correlations at each examination are positive but low, suggesting that the amounts
of fluid on the two sides are largely independent. Since the fluid volumes are
significantly greater on the buccal side at baseline, perhaps the side differences are due
to anatomical differences rather than the nature of the force applied. Figure 4 does
suggest that the disparity between sides increased during the experiment (T2, T3, T4),
and that the difference decreased by T5 after the spring had been removed.
Still, GCF volumes on both sides of the teeth behaved similarly: The smallest
volumes were at baseline, and volumes increased duration of the spring (T2 through
T4). The final readings were (T5) lower than at T2 through T4, but, at least lingually,
had not returned completely to baseline. The lingual crevicular fluid level at day 0 was
1.09 (sd = 0.705) and at day 8 the reading was 1.39 (sd = 0.709), and, by paired t‐test, the
difference was marginally significant (t = 2.1; P = 0.043). The buccal crevicular fluid level
at day 0 was 0.82 (sd = 0.570), and it was 0.97 (sd = 0.695) at day 8. This buccal difference
was not significant (t = 1.28; P = 0.2060).
GCF levels increased following the baseline examination that was collected prior
to spring placement. Visually, there was a sharper and higher rise for the lingual
(compression side) readings than for the buccal samples. Also, the shapes of the curves
were different; there was a more rapid rise on the lingual side, while the volume of the
buccal samples did not reach their maxima until examination T4 (day5). Still, it is
notable that the shapes of the curves, both for the buccal and lingual samples, are fairly
similar given sampling fluctuations. There appears to be some covariation (correlation)
among the sample sites, possibly because the total region is small (two adjacent teeth)
and because of fluid flow and mixing within the crevice of each tooth.
Finally, it is evident in Figures 8 and 9 that once the stressor (the spring) was
removed after data collection at the T4 examination (day 5), the levels of crevicular fluid
diminished. At examination T5 (3 days after spring removal), fluid levels had decreased
to near the baseline level, but were still higher than before the spring was introduced.
Samples from all regions of the crevice were combined into the lingual and
buccal portions, and the sum of these is the complete, circumferential total (Figure 11).
This plot again shows that crevicular fluid is more common on the lingual than the
buccal regions, even at the baseline examination, and that the rise in GCF caused by the
spring is more rapid and greater on the lingual side. Again, it is unclear how dynamic
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Table 3. Results of paired t‐tests between the gingival fluid volumes collected from
the buccal and lingual sides of the four maxillary premolars.
Examination1
Statistic
T1
T2
T3
T4
Total Lingual
1.059
1.774
1.929
1.935
Total Buccal
0.800
0.956
1.034
1.324
Mean Difference
0.259
0.818
0.895
0.611
Std Error
0.105
0.128
0.125
0.116
Upper 95% CL
0.468
1.074
1.147
0.844
Lower 95% CL
0.050
0.562
0.644
0.378
n
58
53
53
53
Correlation
0.20
0.17
0.27
0.47
t‐test
2.48
6.41
7.14
5.26
df
57
52
52
52
P‐value
0.0163
< 0.0001
< 0.0001
< 0.0001
Paired t‐tests were performed at each of the five examinations.
1Statistically significant values are shown in bold font and underlined.
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T5
1.339
0.347
0.991
0.097
1.186
0.796
53
0.48
10.19
52
< 0.0001

Figure 10. Plot of the buccal and lingual volumes of crevicular fluid across the five
examinations.
The five examinations are scaled along the X axis to display the days of the experiment.
Volumes on the lingual (compression) sides were consistently larger than those on the
buccal. Both sides showed increased secretions after the spring was in place, and the
volumes decreased when the stress was removed.
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Figure 11. Plot of the volumes of crevicular fluid in the crevice as a function of site
and time.
The five examinations are scaled along the X axis.
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the fluid flow is around the crevice. It could be, for example, simply that there is more
fluid on the lingual side because the anatomy of the structure causes it to accumulate
there.

Crevicular Fluid: Statistical Examinations
The prior section described the visually‐evident time changes, but the suggestive
trends need to be confirmed statistically. A repeated‐measures analysis of variance
(MANOVA) model was used with the JMP version 9 statistical package (SAS Institute,
Inc., Cary, North Carolina). The generalized linear model module in SPSS version 19
(IBM North America New York) also was used. The five examinations (time) were the
repeated measure, and several dependent variables were tested.

Total Crevicular Fluid
As shown in Figures 8 and 9, there was some concordance in the time change
from the samples collected from the eight sites between the two premolars.
Consequently, rather than detailing the redundant statistical findings, analyses of three
variables are emphasized, namely (1) the summed measures of the four buccal sites, (2)
the summed of the four lingual sites, and (3) the total of all sites (Figure 11).
Buccal GCF Levels. Of course, this was a completely within‐subjects statistical
design. Examining the buccal means, the lowest amount of crevicular fluid (buccal
sides) was invariably at the start of the experiment, prior to spring placement. For the
sums (Figure 12), repeated‐measures ANOVA yields a significant difference among
examinations (F = 4.55; df = 4 and 49; P = 0.0033). The significant F‐ratio indicates that
there was at least one statistically significant difference among the means, but it does not
say where the differences were located. Contrasts (Table 2) were used to test for
differences between the examinations; this method compares each examination to the
initial examination (e.g., Y2‐Y1, Y3‐Y1, Y4‐Y1, and Y5‐Y1). This is an option in JMP, and
it is practical in that each change is compared back to the baseline (pretreatment)
condition. A complementary approach is to test the differences pairwise using paired t‐
tests (Table 3).
Using this approach for the buccal samples (Table 4), fluid levels were elevated
at examination T2 compared to baseline, but not significantly so (P = 0.0547). Likewise,
the average level at examination T3 was absolutely elevated, but not significantly so
compared to baseline. Then there was a substantial increase by examination T4, which
levels were increased by this duration of treatment. And then, by examination T5,
which was three days after spring removal, levels had returned to a level not
significantly different from baseline (P = 0.2061). The interval between examinations T4
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Figure 12. Plot of the volumes of buccal crevicular fluid across the five
examinations.
The five examinations are scaled along the X axis to represent the days of the
experiment.

Table 4.

Results of contrast tests for the buccal volumes of crevicular fluid.
Comparison
1 vs. 2
1 vs. 3
1 vs. 4
1 vs. 5

df
1, 52
1, 52
1, 52
1, 52

F‐ratio
1.90
3.86
16.55
1.64
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P‐value
0.1738
0.0547
0.0002
0.2061

and T5 was three days, which shows that the return to baseline was fairly rapid.
Table 4 (contrasts) is complemented by the matrix of paired t‐tests (Table 5),
which further shows that the source of statistical significance involves T4 alone. That is,
the single source of significance was between T4 and the four other examinations.
Possibilities are that T4 is simply aberrant or that, because it is the longest exposure to
the spring, fluid levels are being up‐regulated because it took that duration of time to
initiate some processes of tooth movement.
Lingual GCF Levels. Figure 11 also plots the sample means for the lingual
samples. By repeated‐measures ANOVA, there was a highly significant change in fluid
quantities among examinations (F = 12.09; df = 4 and 49; P < 0.0001). Contrasts for this
variable (Table 6) show that quantities rose considerably from examinations T1 to T2 (P
< 0.0001), and continued to increase through examination T3. The highest mean level
(Figure 13) was achieved at examination T4, which was the end of spring‐treatment.
Thereafter, following spring removal, levels dropped by examination T5 so that levels
were barely above the baseline level (P = 0.0434). Table 7 (matrix of P‐values from
paired t‐tests) complements the contrasts, emphasizing the significant rise from T1 to T2‐
T3‐T4, and then a significant drop in fluid volumes once the spring was removed.
Total GCF Levels. Changes in total GCF volume are predictable since they are
simply the sums of the prior two volumes just examined (Figure 14). Changes across
examinations were highly significant by longitudinal analysis (F = 10.72; df = 4 and 49; P
< 0.0001). One day of spring‐wear significantly elevated fluid volume, and the mean
was further elevated by day 2 (examination T3). The highest mean was for examination
T4, which was five days of spring wear. The table of paired t‐tests (Table 8) shows that
the source of significance were two‐fold, namely (1) a significant increase in volume
between T1 and T2 when the spring was placed and (2) a significant decrease between
T4 and T5 when the spring was removed. Table 9 lists the contrasts. There was a
maximum GCF volume at T4, and that also was the longest the spring was in place. It is

Table 5. Matrix of P‐values from paired t‐tests to interpret the source of
significance of the MANOVA test for GCF from the buccal sites across the five
examinations.
Group1
Group
T1
T2
T3
T4
T2
0.1738
T3
0.0547
0.4485
T4
0.0002
0.0038
0.0132
T5
0.2060
0.9107
0.5686
0.0015
1Statistically significant values are shown in bold font and underlined.
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Table 6.

Results of contrast tests for the lingual volumes of crevicular fluid.
Comparison
1 vs. 2
1 vs. 3
1 vs. 4
1 vs. 5

df
1, 52
1, 52
1, 52
1, 52

F‐ratio
32.24
31.25
34.66
4.29

P‐value
< 0.0001
< 0.0001
< 0.0001
0.0434

Figure 13. Plot of least‐squares means from MANOVA for lingual gingival
crevicular fluid.
The five examinations are scaled along the X axis to show days of the experiment. The
overall difference among examinations is highly significant (P < 0.0001).
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Table 7. Matrix of P‐values from paired t‐tests to interpret the source of
significance of the MANOVA test for GCF from the lingual sites across the five
examinations.
Group1
Group
T1
T2
T3
T4
T2
< 0.0001
T3
< 0.0001
0.2640
0.2551
0.9684
T4
< 0.0001
T5
0.0434
0.0019
< 0.0001
0.0003
1Statistically significant values are shown in bold font and underlined.

Figure 14. Plot of least‐squares means from MANOVA for total gingival
crevicular fluid.
The five examinations are scaled along the X axis to show days of the experiment.
The differences among examinations were highly significant (P < 0.0001).
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Table 8. Matrix of P‐values from paired t‐tests to interpret the source of
significance of the MANOVA test for GCF sum of sites across the five
examinations.
Group1
Group
T1
T2
T3
T4
T2
< 0.0001
T3
< 0.0001
0.2083
0.0136
0.1500
T4
< 0.0001
T5
0.0426
0.0294
0.0013
< 0.0001
1Statistically significant values are shown in bold font and underlined.

Table 9.
fluid.

Results of contrast tests for the total volumes of crevicular

Comparison
1 vs. 2
1 vs. 3
1 vs. 4
1 vs. 5

df
1, 52
1, 52
1, 52
1, 52

F‐ratio
10.72
25.01
33.82
4.31

46

P‐value
< 0.0001
< 0.0001
< 0.0001
0.0426

unknown when a physiological maximum of fluid could be obtained because the fluid
quantity increased monotonically until the spring was removed at day 5, because there
was no long‐term data. While total volume decreased significantly from T4 to T5, the
value at T5 was still noticeably above the baseline level (P = 0.0426; Table 9). An
interesting detail would be to determine when the fluid levels actually returned to
baseline after five days of spring treatment. Likewise, in an actual orthodontic setting,
how long after appliance placement does it take before fluid levels return to normal?
And, do they increase discernibly at each appointment when new forces are initiated?
Fluid quantities dropped rapidly from day T4 to T5, and the final value was only
slightly elevated compared to the baseline (P = 0.0426). This reiterates the prior findings
that GCF quantities respond quickly to the mechanical stress of a spring, and about as
quickly to its removal. It also raises the question of how fluid levels respond to the
force‐dissipation of arch wires and other appliances between appointments.

Effectors of Fluid Volumes
The analyses above deal with the total sample of subjects, but an aim of this
project was to test for age, sex, and race differences. That is, does the age, or sex, and/or
race of a patient systematically influence his fluid volume response? Repeated‐measures
MANOVA models again were used to test for these possibilities. A three‐way model
(plus time) was used initially; it was a mixed model since race, sex, and age category
were fixed effects, while the five examinations (time) was a repeated measure.
MANOVA results for the data from the buccal sites are listed in Table 10. Time,
as before, was highly significant because fluid levels were responsive to the mechanical
stress of the spring. None of the other effects was significant. By this measure, neither
race, sex, nor age of the patient had a systematic influence on the amount of crevicular
GCF produced.
Table 11 lists the statistical results for the fluid volumes from the lingual sites.
There were highly significant differences among the five examinations, but race, sex, and
age played no discernible role in influencing fluid levels. Race and sex carry very high
P‐values, close to one, so it seems unlikely that either factor influenced fluid levels.
However, age—whether the subject was an adolescent or adult—had a non‐significant
but low probability (P = 0.09). Plotting the mean fluid levels by age category, showed
that adults had the larger mean at all five examinations (Figure 15). The age difference
did not achieve significance (P = 0.09) because of intra‐group variability, but the results
are suggestive, and further work with a larger and more homogeneous sample is
indicated.
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Table 10.
sites.

MANOVA results for crevicular fluid measured from the buccal

Source
Between Subjects
Race
Sex
Age
Race‐x‐Sex
Race‐x‐Age
Sex‐x‐Age
Race‐x‐Sex‐x‐Age

F‐ratio

df

P‐value1

2.71
2.32
0.61
0.61
0.49
2.94
1.31

1, 45
1, 45
1, 45
1, 45
1, 45
1, 45
1, 45

0.1066
0.1345
0.4400
0.4375
0.4872
0.0933
0.2579

Within Subjects
Time
4.13
4, 42
0.0065
Time‐x‐Race
1.32
4, 42
0.2772
Time‐x‐Sex
1.61
4, 42
0.1901
Time‐x‐Age
1.02
4, 42
0.4106
Time‐x‐Race‐x‐Sex
1.88
4, 42
0.1315
Time‐x‐Race‐x‐Age
0.74
4, 42
0.5698
Time‐x‐Sex‐x‐Age
0.91
4, 42
0.4653
T‐x‐R‐x‐S‐x‐A
2.11
4, 42
0.0959
1Statistically significant values are shown in bold font and underlined.
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Table 11.
MANOVA results for crevicular fluid measured from the
lingual sites.
Source
Between Subjects
Race
Sex
Age
Race‐x‐Sex
Race‐x‐Age
Sex‐x‐Age
Race‐x‐Sex‐x‐Age

F‐ratio

df

P‐value1

0.00
0.00
3.00
0.03
0.23
0.82
0.16

1, 45
1, 45
1, 45
1, 45
1, 45
1, 45
1, 45

0.9644
0.9954
0.0900
0.8629
0.6376
0.3706
0.6921

Within Subjects
Time
12.42
4, 42
< 0.0001
Time‐x‐Race
0.73
4, 42
0.5794
Time‐x‐Sex
0.37
4, 42
0.8288
Time‐x‐Age
1.26
4, 42
0.2992
Time‐x‐Race‐x‐Sex
1.10
4, 42
0.3701
Time‐x‐Race‐x‐Age
0.94
4, 42
0.4487
Time‐x‐Sex‐x‐Age
0.79
4, 42
0.5381
T‐x‐R‐x‐S‐x‐A
0.68
4, 42
0.6070
1Statistically significant values are shown in bold font and underlined.
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Figure 15. Plot of the lingual GCF levels for each examination, by age
category.
Though statistically not significant (P = 0.0526) by MANOVA, adolescents
consistently exhibited higher fluid concentrations than adults across the five
examinations.

MANOVA analysis for the total crevicular fluid samples is shown in Table 12.
Race and sex were, again, far from significant, and, statistically, the probability for the
age category is no longer suggestive (P = 0.46). Since “total fluid” is the summation of
the individual’s fluid responses (the total of all samples), it is discussed in more detail.
The variable ‘race’ was consistently non‐significant (Figure 16). Fluid levels did
not differ between these samples of American blacks and whites (P = 0.3880). As for sex
of the patient, there is no suggestion of a difference (Figure 17; P = 0.4376). The
difference between the two age category were visually suggestive of adults having
higher levels, but not significantly so (Figure 18; P = 0.4624).
In sum, the crevicular fluid levels were tested for differences between races
(American black‐white), sexes, and age category (child or adult). Tested with MANOVA,
there was no systematic difference in GCF volumes for any of these variables. Notably,
this three‐way model accounts for sampling inequalities in sample size among race, sex,
and age (i.e., an unbalanced design). This is a parsimonious, objective solution that is
superior (and different) from univariate analysis, where one variable does not control for
the other two. Consistently in these analyses ‘time’—a proxy for the duration of tension
on the teeth by the transpalatal spring—was highly significant. Force from the spring
significantly increased the fluid levels on both the buccal and lingual sides of the tooth.
The longer the spring was in place (a total of 5 days), the greater the GCF levels. It is not
known because of this short interval when the maxima might be reached in actual
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Table 12.
all sites.

MANOVA results for crevicular fluid measured from the total of

Source
Between Subjects
Race
Sex
Age
Race‐x‐Sex
Race‐x‐Age
Sex‐x‐Age
Race‐x‐Sex‐x‐Age

F‐ratio

df

P‐value

0.76
0.61
0.55
0.27
0.45
2.17
0.10

1, 45
1, 45
1, 45
1, 45
1, 45
1, 45
1, 45

0.3880
0.4376
0.4624
0.6092
0.5062
0.1481
0.7475

Within Subjects
Time
11.26
Time‐x‐Race
1.21
Time‐x‐Sex
0.81
Time‐x‐Age
1.34
Time‐x‐Race‐x‐Sex
1.72
Time‐x‐Race‐x‐Age
0.95
Time‐x‐Sex‐x‐Age
0.66
Time‐x‐Race‐x‐Sex‐x‐Age1.58

4, 42
4, 42
4, 42
4, 42
4, 42
4, 42
4, 42
4, 42

< 0.0001
0.3224
0.5259
0.2695
0.1645
0.4472
0.6254
0.1960
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Figure 16. Graph of the crevicular fluid for the total of all sites, by
examination and race.
The five examinations are scaled along the X axis to show days of the experiment.
There was no suggestion of any black‐white race difference in fluid levels.

Figure 17. Graph of the crevicular fluid for the total of all sites, by
examination and sex.
There was no suggestion of any male‐female difference in GCF volumes.
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Figure 18. Graph of the crevicular fluid for the total of all sites, by
examination and age category.
There was a suggestion in these means for adults to have higher fluid levels, but,
statistically, there was no difference (P = 0.4624).

orthodontic settings. Once the force was removed—the spring was removed at day 5—
the fluid levels diminished. By three days after spring removal (day 8), fluid levels were
close to, but slightly above the baseline values.
The next consideration addressed was whether the buccal and lingual collection
sites were different enough that pooling the samples obscured age, sex, or race
differences. For completeness, a series of MANOVA tests was calculated on the sides of
the teeth separately. The first set of tests was for the four buccal sites alone.

GCF Collection Sites
As a starting point, the nature of the distribution of GCF volumes for the total
(B+L) collection sites was assessed (Figure 19). This graph plots the individual data for
each of the longitudinal study, but the times between examinations is constant.
The GCF volumes from the buccal and lingual sites (B + L = total) are fairly
concordant. The GCF volumes from the buccal sites (Figure 20) were tested for a
difference among examinations. Results of the MANOVA test (Table 13) show that time
was indeed statistically significant (F = 4.55; df = 4 and 49; P = 0.0033). The table of
paired t‐tests (Table 14) disclosed that fluid levels were lowest at baseline and increased
through T2, T3, and T4. The highest levels (T4) occurred when the spring was in place
for the longest period of time. Statistically, T1 and T2 were the same, but T3 was
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Figure 19. Boxplots of the volumes of total GCF.
There is a rise in volume by examination 3 that becomes greater by examination 4, but
these appear to be leveraged by a few, large outliers. The shape of the boxplots shows
that the distributions tend to be positively skewed.
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Figure 20. Plot of the volumes of GCF from the buccal sites.
The least‐squares means are plotted for the five examinations. The volumes rose to a
high by T4, when the spring was removed, then dropped to near‐baseline by the final
reading at T5.

Table 13.
MANOVA results testing for age difference in the GCF fluid
volumes on the buccal sites over the five examinations.
Source
Between Subjects
Age Category
Within Subjects
Time
Time‐x‐Age

F‐ratio

df

P‐value

2.55

1, 51

0.1167

4.45
0.55

4, 48
4, 48

0.0038
0.7026
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Table 14.
Matrix of P‐values from paired t‐tests to interpret the source of
significance of the MANOVA test for GCF on the buccal sites across the
five examinations.
Group
Group
T2
T3
T4
T5

T1
0.1738
0.0547
0.0002
0.2060

T2

T3

T4

0.4485
0.0038
0.9107

0.0132
0.5686

0.0015

significantly higher than T1. Then there was a significant drop in volume between T4
and T5 (P = 0.0015), such that the volume at T5 was not significantly different than at
baseline (P = 0.2060).
Lingual GCF Volumes. The natures of the distribution of GCF volumes across
the course of the experiment are shown in Figure 21.
The plot for the lingual sites alone is shown in Figure 22, where there also was a
significant difference across examinations (F = 12.09; df = 4 and 49; P < 0.0001). The
source of significance is interpreted from the table of paired t‐tests (Table 15). There
was a significant increase in fluid from T1 to T2 (P < 0.0001), and the volumes stayed
elevated from T2 through T4, then they dropped after spring removal, but the level at T5
was still significant higher than at baseline (P = 0.0434).
Lingual GCF Volumes: Age Test. The MANOVA test for a difference between
age categories for the lingual volumes of GCF was not significant but suggestively low
(P = 0.0526). The pattern of the data is shown in Figure 23, and the statistical results are
listed in Table 16.
Lingual GCF Volumes: Sex Test. Figure 24 shows the pattern of lingual fluid
levels between the sexes, and females tend to have the larger volumes, but not
significantly so as shown in Table 17 (P = 0.4031). The lack of significance for ‘sex’
suggests that there was considerable variation within the groups.
Lingual GCF Volumes: Race Test. Volumes on the lingual sites were compared
between races (American blacks and whites). The patterns are very similar between the
two races (Figure 25), and these two groups were not statistically different by
MANOVA (Table 18) (P = 0.9460).
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Figure 21. Boxplots of the volumes of GCF at the lingual sites across the five
examinations.
There is a noticeable rise from examination 1 through 4, and then a decrease at
examination 4 after the transpalatal spring was removed at examination 4.
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Figure 22. Plot of the volumes of GCF from the lingual sites.
The least‐squares means are plotted for the five examinations (T1 = day 0, T2 = day
1, T3 = day 2, T4 = day5, and T5 = day 8). The MANOVA result was statistically
significant (P < 0.0001) for differences across time.

Table 15.
Matrix of P‐values to interpret the source of significance of the
MANOVA test for GCF on the lingual sites across the five examinations.
Group
Group
T2
T3
T4
T5

T1
< 0.0001
< 0.0001
< 0.0001
0.0434

T2
0.2640
0.2551
0.0019
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T3

0.9684
< 0.0001

T4

0.0003

Figure 23. Plot of the volumes of GCF from the lingual sites by age.
The least‐squares means are plotted for the five examinations. The MANOVA
result was strictly not statistically significant (P = 0.0526), though the least‐squares
means tend to be higher in adults than adolescents.

Table 16.
MANOVA results testing for age difference in the GCF fluid
volumes on the lingual sites over the five examinations.
Source
Between Subjects
Age Category

F‐ratio
3.94

df
1, 51

P‐value1
0.0526

Within Subjects
Time
12.03
4, 48
< 0.0001
Time‐x‐Age Category
1.33
4, 48
0.2708
1Statistically significant values are shown in bold font and underlined.
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Figure 24. Plot of the volumes of GCF from the lingual sites by sex.
The least‐squares means are plotted for the five examinations. The MANOVA
result was not statistically significant (P = 0.4031), though the least‐squares means
tended to be higher in females than males.

Table 17.
MANOVA results of testing for sex difference in the GCF fluid
volumes on the lingual sites across the five examinations.
Source
Between Subjects
Sex
Within Subjects
Time
Time‐x‐Sex

F‐ratio

df

P‐value

0.71

1, 51

0.4031

11.80
0.02

4, 48
4, 48

< 0.0001
0.8805
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Figure 25. Plot of the volumes of GCF from the lingual sites by race.
The least‐squares means are plotted for the five examinations. The MANOVA result
was not statistically significant (P = 0.9460).

Table 18.
MANOVA results testing for race difference in the GCF fluid
volumes on the lingual sites across the five examinations.
Source
Between Subjects
Race

F‐ratio
0.00

df

P‐value1

1, 51

0.9460

Within Subjects
Time
11.69
4, 48
< 0.0001
Time‐x‐Race
0.46
4, 48
0.7657
1Statistically significant values are shown in bold font and underlined.
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Figure 26 is a boxplot of the GCF lingual volumes between these blacks and
whites (examinations pooled) just to confirm the considerable overlap between these
two races.
Buccal GCF Volumes. The tests just reviewed for the GCF volumes collected
from the lingual tooth sites are now duplicated for the buccal sites. The overall result,
with no dependent variables, is shown in Figure 27. Statistically, the changes across
time were significant statistically (P = 0.0033). The table of paired t‐tests (Table 19)
disclosed that the single source of significance was due to the maximum level seen on
day 5 (T4); the first three samples (T1, T2, T3) were significantly lower than that at T4.
As noted previously, T4 is the longest time the spring was in place, so this maximum
may represent the progressive rise in fluid level prior to removal of the spring.
Buccal GCF Volumes: Age Test. Results of testing for an age difference in the
GCF volumes collected from the buccal sites are shown in Table 20. There was not a
significant difference between the age grades (P =0.1167), but inspection of the LS means
(Figure 28) suggests that adolescents tended to have larger volumes than the adults.
Buccal GCF Volumes: Sex Test. The pattern for GCF volumes across the five
examinations is graphed in Figure 29, and the noticeable difference is that males have
the larger volumes according to these LS means. Results of the MANOVA test (Table
21) showed that the fluid levels did not differ significantly between the sexes, but the
difference (P = 0.0686) is suggestive, with males having the larger volumes, even at
baseline prior to treatment
Buccal GCF Volumes: Race Test. Was there a significant difference between
American blacks and whites in the volumes of buccal GCF volume? The race difference
is graphed in Figure 30, and the MANOVA results are listed in Table 22. The figure
shows that the volumes were not consistently greater in either group. The race
difference was not significant (P = 0.2475).

OPG and RANKL Concentrations
A driving issue in this study was to examine the nature of the distribution of
RANKL and OPG. There was sufficient gingival crevicular fluid to make two assays
from each sample (detailed below), and the results described below (Figures 31 and 32)
were based on the arithmetic average of these duplicate measures. Some of these
averages have concentrations below that detectable by the assay (concentrations not
“zero,” but too low to register), most concentrations for RANKL (Figure 31), were in the
range of 0 to 100, and a few have much higher concentrations. Decidedly, the
distribution is positively skewed. For RANKL, skewness was 4.99 and kurtosis was
37.17—both measures deviate substantially from a Gaussian distribution. Most of the
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Figure 26. Boxplots of the GCF volumes collected from the lingual sites.
There is considerable overlap in the distributions, which accounts for the absence of any
sort of statistical difference between the races.
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Figure 27. Plot of the volumes of GCF from the buccal sites of the premolars.
The least‐squares means are plotted for the five examinations. There is a rise in
fluid till day 5 when the spring was removed, then a significant drop.

Table 19.
Matrix of P‐values from paired t‐tests to interpret the source of
significance of the MANOVA test for GCF on the buccal sites across the
five examinations.
Group
Group
T2
T3
T4
T5

T1
0.1738
0.0547
0.0002
0.2060

T2

T3

0.4485
0.0038
0.9107

0.0132
0.5686
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T4

0.0015

Table 20.
Results of MANOVA testing for a difference in concentrations
of GCF from the buccal sites depending on the subject’s age category.
Test
Between Subjects
Age Category

F‐ratio
2.55

df
1, 51

Within Subjects
Time
4.45
4, 48
Time‐x‐Age Category
0.55
4, 48
1Statistically significant values are shown in bold font and underlined.

P‐value1
0.1167

0.0038
0.7026

Figure 28. Plot of the volumes of GCF from the buccal sites by age category.
The least‐squares means are plotted for the five examinations. The MANOVA
result was not statistically significant (P = 0.1167), though the LS means tend to be
higher in adolescents than adults.
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Figure 29. Plot of the volumes of GCF from the buccal sites of the premolars
by sex.
The least‐squares means are plotted for the five examinations. ‘Sex’ was not
significant across the five tests (P = 0.0686).

Table 21.
Results of MANOVA testing for a difference in concentrations of
GCF depending on the sex of the subjects.
Source
Between Subjects
Sex

F‐ratio
3.46

df
1, 51

Within Subjects
Time
4.44
4, 48
Time‐x‐Sex
1.24
4, 48
1Statistically significant values are shown in bold font and underlined.
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P‐value1
0.0686

0.0039
0.3051

Figure 30. Plot of the volumes of GCF from the buccal sites by race.
The least‐squares means are plotted for the five examinations, but do not achieve
statistical significance (P = 0.2475).

Table 22.
Results of MANOVA testing for a difference in concentrations
of GCF at the buccal sites depending on the race of the subjects.
Source
Between Subjects
Race

F‐ratio
1.37

df
1, 51

Within Subjects
Time
4.45
4, 48
Time‐x‐Race
2.00
4, 48
1Statistically significant values are shown in bold font and underlined.
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P‐value1
0.2475

0.0039
0.1096

Figure 31. Distribution of RANKL in the combined counts of the five
examinations.
The average of the two readings was averaged for each measurement, then T1
through T5 were summed for each person. Clearly, the distribution is positively
skewed, so standard parametric statistics that depend on a normal distribution
would be suspect.
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Figure 32. Distribution of OPG in the combined counts of the five
examinations.
The point is simply to appreciate the non‐normal distribution of the distribution.
Clearly, the distribution is positively skewed, so standard parametric statistics
that depend on a normal distribution would be suspect.
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OPG values were less than 100, but a few exceeded that, rising to a maximum of 345.
For OPG, skewness (Figure 32) was 6.69, and for kurtosis it was 57.69.

OPG and RANKL: Duplicate Measures
An early point of interest was to test for differences between the repeated
samples. There was enough liquid from the dilutions of the gingival crevicular fluid to
divide the volume and determine the readings twice. The question was: How
duplicative were the two runs? Paired t‐tests were calculated, but they are suspect
because the data are highly skewed (positively). More reliably, the nonparametric
Wilcoxon signed rank test (Castellan and Siegel 1988) was used to test for a systematic
difference between readings. Table 23 lists the results for the OPG concentrations, and
Table 24 does likewise for the RANKL data. The five P‐values in each table all were
well above alpha (0.05), confirming the absence of any directional effect. Also, all of the
product‐moment correlations were above 0.90 for the OPG values, but noticeably lower
(around 0.80) for the RANKL concentrations. These differences in repeatability
probably stem from greater difficulties with the RANKL assay. Since each GCF sample
was well homogenized, there was no reason to suspect any difference between first and
second readings, but these tests were conducted for completeness.
The two tests for a difference between the duplicated OPG reading (Table 23)
and RANKL (Table 24) readings are shown at the bottom of the tables. A paired t‐test
was calculated for each of the five examinations, and no test was close to statistical
significance for OPG. The same non‐significant results were obtained from the five
Wilcoxon signed‐rank tests.
A comparable absence of significance occurred for the duplicated RANKL
readings (Table 24). None of the five paired t‐tests and none of the Wilcoxon tests
approached statistical significance. These negative results hardly come as a surprise, but
they do confirm the duplicative nature of the tests. For OPG, the mean differences
between readings ranged between 1 and 6. For RANKL, the mean differences between
readings range from 1 to 24. Individual readings, of course, differed more widely.

Normality of Distributions
It was of interest whether the observed distributions for OPG and RANKL could
be normalized by a transformation. We followed suggestions by Sokal and Rohlf (1995).
Looking at the OPG readings first, the readings for all five examinations were combined,
and skewness was 6.6931. The formula for the standard error of skewness (Sokal and
Rohlf 1995) is
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Table 23.
Descriptive statistics and result of Wilcoxon’s signed rank tests for the
similarity of OPG concentrations in the repeated readings at each examination.
Statistic
OPG first sample
OPG second sample
Mean difference
Std Error
Upper 95%
Lower 95%
n
Correlation
Paired t‐test
df
P‐Value (two tail)
Wilcoxon Signed Rank
Test Statistic S
P‐Value (two tail)

Exam 1
55.7514
49.6072
6.1443
6.4193
19.0316
‐6.7430
52
0.955
0.957
51
0.3430

Exam 2
39.2821
33.4342
5.8479
3.6897
13.2552
‐1.5595
52
0.959
1.585
51
0.1192

Exam 3
38.0950
38.9033
‐0.8083
3.3347
5.8864
‐7.5031
52
0.965
‐0.242
51
0.8094

Exam 4
30.3187
29.2378
1.0809
3.9790
9.0690
‐6.9073
52
0.904
0.272
51
0.7870

Exam 5
32.4065
29.6428
2.7637
3.8969
10.5870
‐5.0596
52
0.935
0.709
51
0.4814

‐35.50
0.6933

67.00
0.4249

‐0.50
0.9951

‐89.50
0.3178

5.50
0.9377
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Table 24.
Descriptive statistics and result of Wilcoxon’s signed rank tests for
the similarity of RANKL concentrations in the repeated readings at each
examination.
Statistic
RANKL first sample
RANKL second sample
Mean difference
Std Error
Upper 95%
Lower 95%
n
Correlation
Paired t‐test
df
P‐Value (two tail)
Wilcoxon Signed Rank
Test Statistic S
P‐Value (two tail)

Exam 1
25.5815
33.8721
‐8.2906
11.0092
13.8114
‐30.3930
52
0.52759
‐0.75306
51
0.4549

Exam 2
15.5958
14.6634
0.9323
1.7835
4.5128
‐2.6482
52
0.74388
0.52276
51
0.6034

Exam 3
14.2113
13.5366
0.6746
1.6817
4.0507
‐2.7015
52
0.89723
0.401171
51
0.6900

Exam 4
16.8944
16.9464
‐0.0520
1.4373
2.8335
‐2.9376
52
0.89982
‐0.03619
51
0.9713

Exam 5
173.3650
196.8850
‐23.5190
28.3811
33.4583
‐80.4970
52
0.58604
‐0.82869
51
0.4111

59.50
0.4635

47.50
0.4982

58.00
0.4254

11.00
0.8996

‐128.00
0.1233
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≈
where n is the sample size, so the critical test for the raw data was exceedingly large (t =
44.1). With the base 10‐logarithmic transformation, skewness became 0.8530, and the
critical test was 5.61. Recall that the logarithm of zero is undefined—and several values
were “zero” because they were below the level of detectability of the assay—so a small
integer (5) was added to all values prior to the transformation so all values were above
zero and the logarithm could be taken. There was a major reduction in skewness with
the log‐transformation, but it was still highly significant statistically. The log‐log
transformation produced skewness of 0.1137, with a corresponding critical test of t =
0.75, which was not a significant departure from normality.
For the RANKL distribution, skewness for the raw scores was 37.1680. The log‐
transform created a skewness of 0.5914, and the corresponding critical ratio was t = 1.95.
This ratio was fractionally less than the critical value of t (= 1.96). In turn, the log‐log
transform made skewness 0.0327, so the critical ratio was t = 0.11, which was well below
the level of significance (alpha = 0.05).
Consequently, use of the log‐log transformation (base 10) adequately normalized
the distributions regarding skewness and kurtosis, making it reasonable to pursue
parametric statistical analysis, both for OPG and RANKL. This creates minor problems
in that the data have to be transformed back to nanograms (and then subtracting the
offset of 5), but it permits the legitimate use of parametric statistics.

OPG and RANKL Concentrations across Time
The nature of the study, simplified, was (1) to measure the pretreatment, baseline
level, then (2) apply tension to the crowns of four teeth for a period of time (T2 through
T4), and finally (3) test the post‐treatment concentrations three days after removal of the
tensioned spring (examination T5). See Figure 33. The data are serial (repeated
measures), so the statistical method needs to match this.
Multivariate analysis of variance (MANOVA) was used to look at the change in
least‐squares means over time (of the log‐log transformed data). As shown in Figure 34,
the least‐squares means for RANKL were highest at baseline, and then dropped to a low
at T2, slowly rising thereafter, but returning fully to baseline by T5. Statistically, though,
there was so much inter‐individual variation that these changes across time are only
marginally significant statistically (F = 2.77; df = 4 and 48; P = 0.0377). The
concentrations decreased from T1 to a low at T3, then increased to essentially baseline
by T5.
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Figure 33. Schematic showing the time‐line of the experiment.
Each box is 1 day, with a total duration of 8 days and five examinations (T1 through T5).

Figure 34. Plot of the least‐squares means by examination for the concentrations of
RANKL in the total sample (with log‐log transformation).
The differences, in this parametric model did achieve statistical significance by
MANOVA (P = 0.0377). The “LS means” are plotted, which are the least‐squares means
provided by the MANOVA output.
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The matrix of P‐values from paired t‐tests (Table 25) showed that the RANKL
concentration by T3 was significantly lower than baseline (T1 and T2). Concentrations
by examinations T4 and T5 were statistically non‐significant compared to T1. In other
words, the change in RANKL concentration was due to the lower concentration at T3.
These findings were unanticipated because the increase in osteoclastogenesis induced by
a transpalatal spring should increase the concentrations of RANKL—RANKL should
increase while OPG should decrease, or RANKL could remain constant and OPG
concentrations decrease, which would also lead to a higher RANKL/OPG ratio thereby
promoting bone resorption (e.g., Meikle 2007).
The descriptive statistics for the log‐transformed RANKL concentrations are
provided in Table 26.
The temporal changes in OPG (as assessed parametrically) are graphed in Figure
35. The highest average concentration was at pretreatment. After tension was placed on
the teeth, the average concentration decreased and did not return to the baseline level by
T5. Statistically, the MANOVA result was significant statistically for these OPG
concentrations (F = 3.63; df = 4 and 48; P =0.0115). This trend is as expected because OPG
should decrease in response to the orthodontic force from the transpalatal spring.
To evaluate the source of significance among the five examinations, a matrix of paired t‐
tests was calculated (Table 27). These values are two‐tail P‐values. In this instance, all
of the significant differences involved examination T1; that is, there was a significant
drop in OPG concentration when the transpalatal spring was applied, and the four
subsequent values remained significantly lower than the T1 value thereafter (T2 through
T5). The T5 concentration was the lowest of the five, so there was no suggestion that
OPG was returning to its baseline value by the end of the experiment.
The descriptive statistics for OPG concentrations are listed in Table 28.

OPG and RANKL: Sources of Variation
A major interest in this study was to test for (1) sex, (2) age, and/or (3) race
differences in the levels of RANK and/or OPG.

Concentrations by Sex
We begin with the examination of the subject’s sex. Does the sex of the person
affect the concentration of RANKL and/or OPG across the five examinations? The log‐
log transformations of the RANKL concentrations were analyzed. Results of the
MANOVA test for RANKL are shown in Table 27. The differences in the concentrations
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Table 25.
Matrix of P‐values to interpret the source of significance of the
MANOVA test for differences in the concentrations of RANKL.
Group1
Group
T1
T2
T3
T4
T2
0.3464
T3
0.0143
0.0873
T4
0.4970
0.6207
0.0040
0.4592
T5
0.9499
0.2434
0.0113
1Statistically significant values are shown in bold font and underlined.

Table 26.
Descriptive statistics for the log‐transformed concentrations of RANKL at
the five examinations.
Statistic
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n

T1
29.727
58.142
8.063
45.914
13.540
52

T2
0.045
0.142
0.020
0.084
0.005
52

T3
0.012
0.137
0.019
0.050
‐0.026
52
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T4
0.055
0.133
0.018
0.092
0.018
52

T5
0.070
0.148
0.021
0.111
0.029
52

Figure 35. Plot of the least‐squares means by examination for the
concentrations of OPG in the total sample (with log‐log transformation).
The differences in this parametric model were significant by MANOVA (P =
0.0115). Parenthetically, without transforming the data, this result was not
significant (P = 0.1156).

Table 27.
Matrix of P‐values to interpret the source of significance of the
MANOVA test for differences in the concentrations of OPG.
Group1
Group
T1
T2
T3
T4
T2
0.0478
T3
0.0142
0.2689
T4
0.0170
0.5316
0.9113
0.0693
0.3153
0.2805
T5
0.0005
1Statistically significant differences are printed in bold and underlined.
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Table 28.
Descriptive statistics for the log‐transformed concentrations of OPG at
the five examinations.
Statistic
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n

T1
0.138
0.192
0.027
0.192
0.085
52

T2
0.088
0.164
0.023
0.134
0.042
52

T3
0.074
0.164
0.023
0.119
0.028
52

T4
0.076
0.149
0.021
0.117
0.034
52

T5
0.054
0.166
0.023
0.101
0.008
52

of RANKL were interpreted using the matrix of P‐values listed in Table 29. Notice that
the inter‐examination differences were driven more by the males in the sample, while
the female subset did not contribute significantly. This test shows that ‘sex’ does not
affect the concentration of RANKL as examined here (P = 0.1513), though the
concentrations were consistently a bit lower in females than males (Figure 36). Change
in OPG across time, of course, also was significant as discussed earlier (P = 0.0394).
The arithmetic means of these variables (total RANKL, by sex) are listed in Table
30.
Looking at the same test for OPG, the results (Table 31) disclosed a marginally‐
significant difference in OPG concentrations by sex (P = 0.0477). As shown in Figure 37,
males consistently had the higher concentration at all five examinations. Again, the
difference across examinations (time) was significant statistically (P = 0.0138). In the
sample for girls the matrix of P‐values (Table 32) shows that the source of significance
primarily involves the high levels of RANKL at T5. In contrast, the data for males
(Table 33) indicates that their difference in OPG primarily was the high, pretreatment
level at T1.

Concentrations by Age
The second variable to be examined was age, where we have dichotomized into
adolescents (under 18 years) and adults (over 18 years). However, it is worthwhile first
to look at the range of ages expressed in years. The descriptive statistics for the
concentrations of OPG by age grade are provided in Table 34. These values are, of
course, log‐transformed. Concentrations (the dependent variable) were regressed on
ages of the subjects (the independent variable). The associations at each of the five
examinations are graphed in Figures 38 through 42.
Table 35 shows the MANOVA results of testing for RANKL concentrations by
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Table 29.
MANOVA results testing for a sex difference in the
concentrations of RANKL over the five examinations.
Source
Between Subjects
Sex
Within Subjects
Time
Time‐x‐Sex

F‐ratio

df

P‐value

2.12

1, 50

0.1513

2.74
0.26

4, 47
4, 47

0.0394
0.9044

Figure 36. Plot of a MANOVA for the concentrations of RANKL across
examinations by sex.
Plot is of the log‐log transformation of RANKL (plus 5). Males consistently
exhibited higher mean concentrations across all five examinations, though the
difference between sexes was not significant (P = 0.1513).
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Table 30.

Arithmetic means for RANKL, by sex, at the five examinations.
Statistic

Female
Male
Total GCF d1
Mean
1.740
2.006
Std Deviation
1.027
0.884
Std Error of Mean
0.182
0.173
Upper 95% Mean
2.111
2.363
Lower 95% Mean
1.370
1.649
n
32
26
Total GCF d2
Mean
2.544
2.939
Std Deviation
1.010
1.185
Std Error of Mean
0.191
0.237
Upper 95% Mean
2.936
3.428
Lower 95% Mean
2.153
2.450
n
28
25
Total GCF d3
Mean
3.008
2.914
Std Deviation
1.307
1.067
Std Error of Mean
0.247
0.213
Upper 95% Mean
3.514
3.355
Lower 95% Mean
2.501
2.474
n
28
25
Total GCF d4
Mean
3.247
3.271
Std Deviation
1.339
1.450
Std Error of Mean
0.253
0.290
Upper 95% Mean
3.766
3.870
Lower 95% Mean
2.728
2.673
n
28
25
Total GCF d5
Mean
2.383
2.224
Std Deviation
1.277
1.189
Std Error of Mean
0.241
0.238
Upper 95% Mean
2.879
2.715
Lower 95% Mean
1.888
1.733
n
28
25
The units are ng/ml. These are identical to the values plotted in Figure 36.
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Table 31.
MANOVA results testing for a sex difference in the concentrations of
OPG over the five examinations.
Source
Between Subjects
Sex

F‐ratio

df

P‐value1

4.1221

50

0.0477

Within Subjects
Time
3.5075
4, 47
0.0138
Time‐x‐Sex
1.2452
4, 47
0.3049
1Statistically significant values are shown in bold font and underlined.

Figure 37. Plot of a MANOVA for the concentrations of OPG across
examinations by sex.
Plot is of the log‐log transformation of OPG (plus 5). Males consistently
exhibited higher concentrations across all five examinations.
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Table 32.
Matrix of P‐values to interpret the source of significance of the
MANOVA test for differences in the concentrations of RANKL.
Group
Group
T1
T2
T3
T4
T5
T1
‐‐
0.9740
0.2547
0.9312
0.6798
T2
0.1749
‐‐‐
0.1941
0.9125
0.6553
0.2792
‐‐‐
0.0502
0.1289
T3
0.0128
‐‐‐
0.7499
T4
0.2785
0.4869
0.0380
T5
0.7146
0.2381
0.0360
0.4492
‐‐‐
1Results for girls are shown in the upper right half of the matrix; boys are listed in
the lower left diagonal.
1

Table 33.
Matrix of P‐values to interpret the source of significance of the
MANOVA test for differences in the concentrations of OPG.
Group1
Group
T1
T2
T3
T4
T5
T1
‐‐‐
0.5629
0.3762
0.4346
0.0272
T2
0.0067
‐‐‐
0.5151
0.8251
0.0256
0.3667
‐‐‐
0.8356
0.0507
T3
0.0041
T4
0.0053
0.4747
0.9334
‐‐‐
0.0444
0.9794
0.5689
0.5061
‐‐‐
T5
0.0035
1Results for girls are shown in the upper right half of the matrix; boys are listed in
the lower left diagonal.
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Table 34.
Descriptive statistics, by sex, for the levels of total OPG at
each examination.
Statistic
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n

Female
loglog(OPG) T1
0.085
0.201
0.038
0.163
0.007
28
loglog(OPG) T2
0.062
0.156
0.029
0.123
0.002
28
loglog(OPG) T3
0.051
0.154
0.029
0.110
‐0.009
28
loglog(OPG) T4
0.056
0.147
0.028
0.113
‐0.001
28
loglog(OPG) T5
0.000
0.150
0.028
0.059
‐0.058
28
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Male
0.200
0.165
0.034
0.269
0.131
24
0.118
0.172
0.035
0.191
0.045
24
0.100
0.176
0.036
0.175
0.026
24
0.099
0.152
0.031
0.163
0.034
24
0.117
0.165
0.034
0.187
0.047
24

Figure 38. The plot of OPG at T1 regressed on the subject’s age in years.
The regression equation is loglog(OPG) = 0.2389 ‐ 0.0038(age), where the
intercept (P < 0.0001) and the regression coefficient (P = 0.0499) are statistically
significant.
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Figure 39. The plot of OPG at T2 regressed on the subject’s age in years.
The regression equation is loglog(OPG) = 0.2120 ‐ 0.0047(age), where the intercept (P <
0.0001) and the regression coefficient (P = 0.0038) are statistically significant.
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Figure 40. The plot of OPG at T3 regressed on the subject’s age in years.
The regression equation is loglog(OPG) = 0.1298 ‐ 0.0021 (age), where the intercept (P =
0.0113) is statistically significant but the regression coefficient (P = 0.2057) is not.
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Figure 41. The plot of OPG at T4 regressed on the subject’s age in years.
The regression equation is loglog(OPG) = 0.1034 ‐ 0.0011(OPG), where the intercept (P =
0.0270) is statistically significant but the regression coefficient (P = 0.4927) is not.
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Figure 42. The plot of OPG at T5 regressed on the subject’s age in years.
The regression equation is loglog(OPG) = 0.1641 ‐ 0.0042, where the intercept (P = 0.0112)
is statistically significant and so is the regression coefficient (P = 0.0124).

Table 35.
Results of MANOVA testing for differences in concentrations of
RANKL depending on the subject’s age category.
Source
Between Subjects
Age Category
Within Subjects
Time
Time‐x‐Age Category

F‐ratio

df

P‐value

0.0034

1, 50

0.9535

2.702
0.4634

4, 47
4, 47

0.0416
0.7622
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age grade. There was no evidence of a difference between age grades (P = 0.9535), and
this is shown graphically in Figure 43. Indeed, the means were very close together at T1,
T3, and T5, and the concentrations by age grade were in opposite rankings at T2 and T4.
The descriptive statistics for the concentrations of RANKL by age grade are
provided in Table 36. These values are, of course, log‐transformed.
Turning to the RANKL data, the regression of age of the subject at examination is
regressed on the RANKL concentration as it was for OPG, and these results are shown
in Figures 44 through 48.
The results of linear regression analyses for OPG are listed in Table 37, and the
interesting finding is that three of the five tests (T1, T2, and T5) achieved statistical
significance In each case, as shown in the graphs (Figures 38 through 42), the
association was negative: Older subjects (adults) had lower concentrations of OPG than
the adolescents. (The intercepts also are all significant, but they have no relevance in
these tests.) Visually assessing the relationships between OPG and age shows no
inflection point; the decrease appears to be linear with age, though there is a good deal
of inter‐individual variation.
The use of the two age categories (adolescent or adult) in place of the continuous
variable (age in years) was tested. Results of ANOVA for each of the five examinations

Figure 43. Plot LS means for the concentrations of RANKL in the two age grades
across the five examinations.
Values are the log‐log transformation of the raw values (plus 5). There seems to be
no patterned difference by age grade across time.
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Table 36. Descriptive statistics, by age grade, for the levels of RANKL at
each examination.
Statistic
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n

Adult
log(RANKL) T1
0.071
0.164
0.031
0.135
0.007
28
log(RANKL) T2
0.034
0.148
0.028
0.091
‐0.024
28
log(RANKL) T3
0.018
0.141
0.027
0.073
‐0.036
28
log(RANKL) T4
0.068
0.130
0.025
0.119
0.018
28
log(RANKL) T5
0.064
0.145
0.027
0.120
0.008
28

90

Child
0.066
0.152
0.031
0.130
0.002
24
0.058
0.136
0.028
0.115
0.001
24
0.006
0.135
0.028
0.063
‐0.051
24
0.040
0.138
0.028
0.098
‐0.019
24
0.077
0.155
0.032
0.142
0.012
24
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Figure 44. The plot of RANKL at T1 regressed on the subject’s age in years.
The regression equation is loglog(RANKL) = 0.114 ‐ 0.0017, where the intercept
(P = 0.0196) but not the regression coefficient (P = 0.2840) is statistically
significant.
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Figure 45. The plot of RANKL at T2 regressed on the subject’s age in years.
The regression equation is loglog(RANKL) = 0.1199 ‐ 0.0028, where the intercept
(P = 0.0058) and the regression coefficient (P = 0.0478) are statistically significant.
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Figure 46. The plot of RANKL at T3 regressed on the subject’s age in years.
The regression equation is loglog(RANKL) = 0.0474 ‐ 0.0013, where neither the
intercept (P = 0.2565) nor the regression coefficient (P = 0.3440) is statistically
significant.
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Figure 47. The plot of RANKL at T4 regressed on the subject’s age in years.
The regression equation is loglog(RANKL) = 0.0789 ‐ 0.0009, where neither the
intercept (P = 0.0563) nor the regression coefficient (P = 0.5111) is statistically
significant.
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Figure 48. The plot of RANKL at T5 regressed on the subject’s age in years.
The regression equation is loglog(RANKL) = 0.1312 ‐ 0.0023, where the intercept
(P = 0.0044) but not the regression coefficient (P = 0.1236) is statistically
significant.
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Table 37.
Results of linear regression at each of the five examinations testing for an
association between subject’s age and concentration of OPG.
Term

Estimate
Std Error
t ratio
P‐value1
loglog(OPG) T1 by age (years)
Intercept
0.238927
0.056394
4.24
< 0.0001
Age (years)
‐0.003830
0.001904
‐2.01
0.0499
loglog(OPG) T2 by age (years)
Intercept
0.211993
0.046088
4.60
<.0001
Age (years)
‐0.004720
0.001556
‐3.03
0.0038
loglog(OPG) T3 by age (years)
Intercept
0.129828
0.049357
2.63
0.0113
Age (years)
‐0.002140
0.001666
‐1.28
0.2057
loglog(OPG) T4 by age (years)
Intercept
0.103365
0.045363
2.28
0.0270
Age (years)
‐0.001060
0.001531
‐0.69
0.4927
loglog(OPG) T5 by age (years)
Intercept
0.164051
0.047651
3.44
0.0012
0.0124
Age (years)
‐0.004180
0.001609
‐2.60
1The Y‐intercepts, though statistically significant, are not highlighted because they have
no relevance here, but 3 of the 5 regression coefficients achieved significance (two‐tail
tests).
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is shown in Table 38, and results were that just one of the five age categories was
statistically significant (T2; P = 0.0084). This means there was less detection capability
using the categorical data for age.
Table 39 shows the results of a MANOVA testing for a difference by subject’s
age (graphed in Figure 49). Age is statistically significant (P = 0.0227). Figure 50 shows
that children have higher levels of OPG while the levels in adults are lower.
The descriptive statistics associated with these tests (i.e., OPG against age grade)
are listed in Table 40.

Black‐White Racial Variation
This appears to be the first time for RANKL or OPG to be tested for a race
difference. American blacks and whites were compared primarily because of the ready
available of these two groups at our orthodontic clinic. MANOVA results for the
concentrations of OPG across the five examinations are listed in Table 41 and graphed
in Figure 51. There is no suggestion of a race difference (P = 0.8351). The plots of the LS
means are virtually superimposed by race.
The descriptive statistics for RANKL concentrations at the five examinations,
partitioned by race, are listed in Table 42.
Turning to the data for OPG, there also was no statistically significant
difference between the races in this analysis (Table 43), but the results in Figure 52
are interesting because the OPG concentrations in blacks all are higher than in
whites. There is the possibility, then, that a larger and more homogeneous group
(e.g., restricted ages) would produce significant results between these two races.
The descriptive statistics for OPG partitioned by race are listed in Table 44.

The RANKL by OPG Ratio
Osteoclastogenesis is characterized by an increase in the concentration of
RANKL and a decrease in OPG (Kanzaki et al. 2001; Liebbrandt and Penninger 2008), so
the ratio of RANKL‐to‐OPG should increase with progressive osteoclastic activity.
Figure 53 plots the concentrations of RANKL and OPG (in the loglog transformed
domain). Broadly, the concentration of OPG decreased with the duration of the force of
the transpalatal spring, though there was no apparent recovery after spring removal.
RANKL concentration initially dropped but then rose with duration, though it too
exhibited little recovery after spring removal. There is the suggestion that these
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Table 38.
ANOVA results testing for a difference in OPG concentrations between
age categories.
Source

df

Mean Square

F Ratio

P‐value

One‐way analysis of loglog(OPG) T1 by age category
Age Category
1
0.0654
1.80
Error
50
0.0364
Corrected Total
51
One‐way analysis of loglog(OPG) T2 by age category
Age Category
1
0.1805
7.53
Error
50
0.0240
Corrected Total
51
One‐way analysis of loglog(OPG) T3 by age category
Age Category
1
0.0266
0.98
Error
50
0.0271
Corrected Total
51
One‐way analysis of loglog(OPG) T4 by age category
Age Category
1
0.0018
0.08
Error
50
0.0228
Corrected Total
51
One‐way analysis of loglog(OPG) T5 by age category
Age Category
1
0.0663
2.46
Error
50
0.0269
Corrected Total
51

Table 39.
Results of MANOVA testing for differences in concentrations of
OPG depending on the subject’s chronological age.
Test
Between Subjects
Age Category
Within Subjects
Time
Time‐x‐Age

F‐ratio

df

P‐value

5.532

1, 50

0.0227

3.5831
2.9508

4, 47
4, 47

0.0125
0.0295
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0.1861

0.0084

0.3267

0.7811

0.1230

Figure 49. Plot of the least‐squares means in the concentrations of OPG
pooling the entire sample.
Values are the log‐log transformation of OPG (plus 5).

Figure 50. Plot of LS mean concentrations for OPG categorized by subject’s
age (adolescent, adult).
The concentration in the adolescents is higher at all examinations.
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Table 40.
Descriptive statistics, by age grade, for the levels of OPG at
each examination.
Statistic
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n

Adult
log(OPG) T1
0.105
0.205
0.039
0.185
0.026
28
log(OPG) T2
0.033
0.153
0.029
0.093
‐0.026
28
log(OPG) T3
0.053
0.168
0.032
0.118
‐0.012
28
log(OPG) T4
0.070
0.147
0.028
0.127
0.013
28
log(OPG) T5
0.021
0.165
0.031
0.085
‐0.043
28
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Child
0.177
0.173
0.035
0.250
0.103
24
0.151
0.157
0.032
0.218
0.085
24
0.098
0.161
0.033
0.166
0.030
24
0.082
0.156
0.032
0.148
0.016
24
0.093
0.163
0.033
0.162
0.024
24

Table 41.
Results of MANOVA testing for differences in concentrations of
RANKL depending on the subject’s race.
Test
Between Subjects
Race
Within Subjects
Time
Time‐x‐Race

F‐ratio

df

P‐value

0.0438

1, 50

0.8351

2.7744
0.3103

4, 47
4, 47

0.0377
0.8697

Figure 51. Graph of RANKL concentrations at the five examinations partitioned by
subjects’ race (American black or white).
RANKL values are the log‐log transformations (plus 5). There was no statistically
significant difference in concentrations between the two races (P = 0.8351).
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Table 42.
by race.

Descriptive statistics for RANKL concentrations partitioned

Statistic
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n
Mean
Std Deviation
Std Error Mean
Upper 95% Mean
Lower 95% Mean
n
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n

African
American
log(RANKL) T1
0.062
0.157
0.029
0.121
0.002
29
log(RANKL) T2
0.045
0.147
0.027
0.101
‐0.011
29
log(RANKL) T3
0.011
0.134
0.025
0.062
‐0.040
29
log(RANKL) T4
0.044
0.128
0.024
0.093
‐0.004
29
log(RANKL) T5
0.075
0.146
0.027
0.131
0.019
29

102

American
White
0.078
0.160
0.033
0.147
0.008
23
0.045
0.139
0.029
0.105
‐0.015
23
0.014
0.144
0.030
0.076
‐0.048
23
0.069
0.141
0.029
0.130
0.008
23
0.064
0.153
0.032
0.130
‐0.003
23

Table 43.
Results of MANOVA testing for differences in concentrations of
OPG depending on whether the subject is American black or white.
Source
Between Subjects
Race
Within Subjects
Time
Time‐x‐Race

F‐ratio

df

P‐value

1.39

1, 50

0.2440

3.47
1.34

4, 47
4, 47

0.0145
0.2683

Figure 52. Plot of OPG concentrations at the five examinations, partitioned by
the subject’s race.
There was no statistically significant difference (P = 0.2440) by this grouping.
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Table 44.
race.

Descriptive statistics for OPG concentrations partitioned by

Statistic
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n
Mean
Std Deviation
Std Error of Mean
Upper 95% Mean
Lower 95% Mean
n

African
American
loglog(OPG) T1
0.166
0.192
0.036
0.239
0.093
29
loglog(OPG) T2
0.112
0.155
0.029
0.171
0.053
29
loglog(OPG) T3
0.106
0.167
0.031
0.169
0.042
29
loglog(OPG) T4
0.075
0.148
0.027
0.131
0.019
29
loglog(OPG) T5
0.072
0.173
0.032
0.138
0.006
29
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American
White
0.104
0.191
0.040
0.186
0.021
23
0.058
0.174
0.036
0.133
‐0.018
23
0.033
0.156
0.033
0.101
‐0.034
23
0.076
0.155
0.032
0.143
0.009
23
0.032
0.158
0.033
0.100
‐0.037
23

Figure 53. Plots for the concentrations of RANKL and OPG shown on the same
graph.
Data were loglog transformed (plus 5).

concentrations are slow to return to equilibrium after spring removal (just 3 days).
These data suggest that the RANKL/OPG ratio ought to change little until after day 2,
when it appears that OPG becomes less common, which would increase the
RANKL/OPG ratio.
Figure 54 is a plot of the RANKL/OPG ratio against time. For clarity, this ratio
was calculated by first transforming the individual data and then taking the ratio:
LogLog RANKL 5
LogLog OPG 5
There is no apparent change from baseline to day 1, but then both molecules
drop in concentration by day 2 (more so with OPG), and the ratio spikes dramatically at
day 2. This erratic pattern is due to a few outliers at day 2.
Using the MANOVA test relied on before, there is no change among the five
examinations (F = 0.62; df = 4 and 25; P = 0.6514), but this is distorted by the extreme
sample variance at day 2. Table 45 shows the attempt at making order of the data by
applying Wilcoxon’s signed rank tests to the 10 comparisons pairwise. The table lists
the P‐values, and none of the tests were significant.
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Figure 54.

Plot of the RANKL/OPG ratio against time.

Table 45.
Matrix of P‐values from Wilcoxon signed‐rank tests based on paired data
between observations in the RANKL/OPG ratios.
Group
Group
T2
T3
T4
T5

T1
0.6896
0.9245
0.9294
0.8074

T2

T3

0.7280
0.5330
0.8911

0.8911
0.6050
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T4

0.6411

CHAPTER 5.

DISCUSSION

Gingival Crevicular Fluid Volume
The present study was designed to evaluate changes in the expression of RANKL
and OPG in gingival crevicular fluid (GCF) before, during, and after the application of
an orthodontic force in both growing and non‐growing humans. GCF samples were
collected at the maxillary premolar sites at five different time points over an 8 day
period (Figure 5). A baseline sample was collected prior to force application (T1); three
samples were collected during force application (by a nickel titanium spring), namely at
days 1, 2, and 5 (T2, T3, and T4 respectively); and a final sample was collected 3 days
after force removal (T5).

Crevicular Fluid
Results show a significant increase in GCF levels for both the tension and
compression sides following force application. GCF levels progressively increased from
baseline (T1) at each time point (T2 through T4) until spring removal (T4). The buccal
and lingual levels of GCF returned toward baseline after force removal; however, the
lingual fluid levels at T5 were significantly higher than those at baseline (T1). The
results of this study suggest that increased GCF volumes are related to orthodontic tooth
movement.
Evaluation of the buccal and lingual GCF levels revealed a significantly higher
amount of GCF on the lingual collection sites than on the buccal sites. On the buccal, the
only source of significant increase in GCF was seen at T4. Conversely, a statistically
significant increase was seen at every time point (T2, T3, and T4) for the lingual
collection sites. The anatomical shape of each tooth and therefore its surrounding sulcus
may partially be responsible for the differences seen in the GCF levels on each side of
the tooth, but the applied mechanical force plays a significant role in the increased
production of GCF.
Total GCF volumes increased significantly at each reading following force
application (Figure 10); therefore force application increases the amount of GCF found
in the sulcus. After force removal, the volumes of GCF significantly dropped, which is
suggestive of the sulcus returning to its homeostatic state following the removal of a
mechanical force. These results suggest that GCF quantities respond quickly to
mechanical stress, and about as quickly to its removal.
Sequential increases in GCF volumes were seen during the period of force
application. The tension of the spring was set in a range of 150 to 250 grams of force,
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which is the range suggested by Storey and Smith (1952) for optimum tooth movement.
Since a nickel titanium spring was used, an approximately constant force was delivered
to the premolars over the 5‐day period due to its superelastic properties (Muira et al.
1988). We speculate that a constant mechanical force results in an uninterrupted
stimulus to the cells of the periodontal ligament (PDL) and alveolar bone, which then
will produce a steady state of bone turn‐over. If another material had been used, such as
elastomeric chain or elastic rubber bands, the amount of GCF produced could be
expected to decrease significantly over time due to force decay.
Previous reports regarding the effect of orthodontic tooth movement on the GCF
have been conflicting. Tersin (1978) observed gingival exudation during orthodontic
treatment, and concurrently he reported an increase in GCF volumes during mechanical
force application. Baldwin et al. (1999) also reported an increase in GCF volume induced
by orthodontic tooth movement. Yamaguchi et al. (2009) reported on differences in
levels of GCF between conventional and Damon bracket systems. This study revealed
that increases in GCF were less noticeable with the Damon bracket system, which the
authors attributed to the passive ligation system with less inherent friction. Conversely,
both Miyajima et al. (1991) and Uematsu et al. (1996) reported no statistical difference
between the amount of fluid expressed around teeth undergoing orthodontic movement
and control teeth. A current study investigating the change in volume of GCF exudate
during canine retraction reported a slight, but non‐significant, increase GCF levels
(Dannan et al. 2009). Most recently, a study with similar methodology to ours reported a
significant increase in GCF volumes during orthodontic force application, as well as a
significant decrease towards baseline GCF levels following force removal (Hamman et
al. 2009).

Demographic Predictors of Gingival Crevicular Fluid Volume
An aim of this study was to evaluate the effects of mechanical stress caused
during tooth movement and its response in different ages, sexes, and races. Due to the
different variables being tested and the available participant pool, it was impossible to
recruit balanced and equal groups regarding sex, age, and race. A larger number of
participants were enrolled in the study than previous studies to compensate for the
sampling inequalities.
When looking at the buccal and lingual sites individually, no significant
difference was found with regard to age, sex or race. However, adult participants
showed a higher mean amount of GCF at all time points when compared to the
adolescent group for the lingual collection sites. The increased lingual fluid amount was
not significant (P = 0.09); however, it was highly suggestive. A study with a larger, more
homogenous sample would help correct for the intra‐group variability in this study.
Interestingly, but not statistically significant, females had higher levels of GCF collected
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from their lingual sites, while males, on the contrary, had higher levels of GCF collected
from their buccal sites. The amount of GCF collected from both Caucasians and African
Americans were nearly identical, and therefore not statistically significant. There is no
reason to suspect that American blacks and whites would produce different GCF levels.
The comparison was simply made because the comparison was available at our
institution.
Some studies have reported a decrease in crevicular fluid flow in response to
localized and systemic medication; however, these medications should not have
impacted the results of our study due to the stringent selection criteria. Heasman and
Seymour (1989) indicated that the NSAID flurbiprofen (Ansaid®) decreased the amount
of crevicular fluid flow after 3 weeks of use. In 2006, a study by Eviö et al. reported that
alendronate (Fosamax®), which is used in the treatment of bone loss associated with
menopause, significantly decreased the crevicular fluid flow. Antibiotics, either topical
or systemic, appear to have no affect on the gingival crevicular fluid flow (Asikainen et
al. 1990; Ozcan et al. 2004; Pendrill and Reddy 1980; Tanner et al. 1994).
When evaluating the changes in gingival crevicular fluid in response to
mechanical force, it appears that time is the significant factor regardless of the person’s
age, sex, or race. The limiting factor in the amount of GCF produced was dependent on
the amount of time the spring was in place. Force from the spring increased the amount
of crevicular fluid produced on both the buccal and lingual sides of the tooth. After the
spring was removed, the stimulus for increased GCF was gone, and the fluid levels
returned to near pre‐treatment levels. The short timeline of the current study is a
limitation, and a more in depth clinical study during actual orthodontic cases would
reveal a broader, more realistic view of the changes in GCF levels during orthodontic
treatment. An in‐depth longitudinal study would reveal the point at which the GCF
levels peak, flatten out, and then return to baseline.

RANKL and OPG Detectability
Gingival crevicular fluid is an exudate produced by the periodontal tissues.
When the periodontium is healthy, only negligible amounts of gingival crevicular fluid
is produced. On the other hand, production significantly increases in the presence of
gingival inflammation. Research has shown that GCF production is increased in
response to bacterial insult such as gingivitis (Brecx et al. 1987). During orthodontic
tooth movement, however, only part of the increase in production of GCF can be
attributed to inflammation caused by increased plaque retention (Samuels et al. 1993). It
has also been reported that GCF production increases even when subjects undergo
adequate plaque control (Tersin 1978). In the present study, the participants were
required to perform adequate measures to prevent plaque retention around the spring
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apparatus. By encouraging good plaque control standards, the present study tried to
achieve a control mechanism for false positives in the collection of data.
The forces produced during mechanical tooth movement, as seen in
orthodontics, will produce an acute generalized inflammatory reaction in the
periodontal tissues (Kyrkanides et al. 2000). The immediate increase in the flow of
gingival crevicular fluid is caused by the mechanical compression of the
microvasculature of the periodontal ligament (PDL) resulting in an increased fluid
volume in the crevicular space. This reaction causes areas of hyalinization to occur due
to capillary constriction. Consequently, this chain of events leads to the initiation of an
inflammatory reaction (Murrell et al. 1996). The release of a host of chemical mediators
by the cells of the PDL in response to the areas of localized aseptic necrosis changes the
composition of the GCF expressed into the gingival sulcus. This has been demonstrated
by a number of studies where expression of pro‐inflammatory cytokines in GCF tend to
increase in response to mechanical forces (Dudic et al. 2006; Iwasaki et al. 2005; Rohaya
et al. 2009; Uematsu et al. 1996). In the present study, the identification of RANKL and
OPG were identified in the majority of the samples; however, there were still many
instances in which the levels of RANKL and/or OPG were below the level of
detectability for the sensitivity of the assays that were used.
In the few publications regarding the collection of GCF to examine RANKL and
OPG, the results have been minimal and conflicting. There appears to be a significant
problem in consistently detecting both RANKL and OPG from the samples of crevicular
fluid. Bostanci et al. (2007) reported finding minimal levels of RANKL in patients with
healthy gingiva and gingivitis, while finding OPG in all subjects. In contrast, Lu et al.
(2006) did not find OPG in the GCF of any of his fourteen human subjects with healthy
periodontium. Toygar (2008) et al. found OPG in the GCF of teeth undergoing
orthodontic retraction and teeth not undergoing orthodontic mechanics. A recent study
with a similar experimental protocol by Hamman et al. (2009) reported only 21.6%
RANKL and 2.92% OPG detectability, meaning that most of the samples had
concentrations below the level of detectability.
A likely explanation for the differences in cytokines detection is the differences in
assay sensitivity among these different studies. In an attempt to overcome this
limitation, several changes in protocol were introduced in this study. First, the perio
paper strip was allowed to remain in the sulcus for a full minute to allow it to absorb as
much GCF as possible. Also, the samples of the dropout participants were used to
obtain a dilution factor in the laboratory that enabled a minimal amount of buffer to be
used to extract the RANKL and OPG, which allowed detection of a maximum amount of
RANKL and OPG with less background noise. The present study also incorporated
sample “pooling” and duplicate measurements to attempt to increase the likelihood of
achieving a detectable levels of RANKL and OPG. Technology in the development of
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the assay kits most likely has improved over time as well, which allowed for a greater
sensitivity and detectability of smaller amounts of RANKL and OPG.
Inevitably, when looking back at the current protocol, one can see certain areas
that could be improved upon which might make the experiment more predictable.
Primarily, a more efficient collection mechanism would allow for higher percentage of
the GCF to be analyzed. Currently, the perio paper strips are the only dependable and
measureable way to collect crevicular fluid. An inherent problem with the strips is the
fluid and extraction buffer become trapped in the strip, which make it impossible to
remove from the strip for the assaying procedures. Therefore, a significant amount of
the sample plus buffer is lost. In order to achieve enough of a sample to assay,
additional extraction buffer is added. The additional buffer possibly causes over‐
dilution of the sample, which leads to the levels of RANKL and OPG being below the
level of detection of the assay. Consequently, if another reliable transport system is
developed to correct for this problem, then it should be used.

RANKL and OPG Concentrations
To date, no publications are known on the in vitro evaluation of RANKL and
OPG in response to mechanical forces in humans. Multiple studies exist on the
evaluation of RANKL and OPG in rats and in extracted teeth. The present study
evaluated the concentrations of both RANKL and OPG over time, and then evaluated
the concentrations of these biomolecules with regard to three sources of variation,
namely sex, age, and race.
The raw data results for both RANKL and OPG exhibited high levels of
skewness. A log‐log transformation was used to normalize these distributions, which
allowed parametric statistical analysis. These transformations satisfactorily decreased
the skewness and kurtosis, so the tests of the transformed distributions did not differ
from normality.

RANKL and OPG Concentrations versus Time
As previously discussed, RANKL and OPG competitively regulate the body’s
bony metabolism. RANKL is a profound inducer of bone destruction, while OPG plays
a reverse role to inhibit bony breakdown and serves as a protector of bone. RANK and
OPG competitively bind to RANKL on preosteoclasts (Ikeda et al. 2001); consequently,
whichever molecule (RANK or OPG) binds first will determine the fate of the
surrounding bone.
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RANKL expression by osteoblasts is required for osteoclastogenesis and for
maturation of osteoclast precursor cells, and osteoblasts can also stimulate rapid bone
resorption by activating pre‐existing osteoclasts (Boyle et al. 2003). RANKL partially
regulates the survival of mature osteoclasts by increasing their mean survival time
(Feige 2001; Suda et al. 1999). However, RANKL is not required for mature osteoclast
function, which can be regulated by other cytokines such as M‐CSF and TRAF6. After
RANKL stimulates osteoclast formation and activation, their continued function
depends on other cellular messages received by cell to cell interaction via cytokines with
osteoblasts (Arai et al. 1999; Burgess et al. 1999). Therefore, peak osteoclastic activity
may not coincide with the peak RANKL expression. The increase in RANKL expression
by osteoblasts may occur much sooner after the initiation of orthodontic force.
OPG competitively inhibits and reversibly binds to the RANKL site of
preosteoclasts (Yasuda et al. 1998). This competitive, yet reversible, binding inhibits
osteoclastogenesis by terminating their differentiation into mature osteoblasts (Kanzaki
et al. 2005). OPG has profound inhibitory effects on osteoclast differentiation and bone
resorption, and its full name, osteoprotegerin, literally means protector of bone
(Liebbrandt and Penninger 2008). OPG expression is regulated by the same hormones
and proteins found naturally in the body that also are influential in the body’s bony
metabolism (Horowitz et al 2001).
In this study, RANKL concentrations decreased significantly over the time the
spring was in place. Unexpectedly, the levels of RANKL were lowest at T3, or 48 hours
after spring activation. RANKL acted contrary to expectations by decreasing from
baseline with an increased time of force application, then rebounding toward baseline
after the removal of the force. The amount of RANKL should have increased in a time‐
dependent manner following force application due to the increased osteoclastogenesis
induced by the transpalatal spring. However, the increase in the RANKL/OPG ratio is
also accomplished by a decrease in OPG concentrations, while the RANKL
concentrations remain constant. The end result would be the same for either scenario
meaning higher amounts of free RANKL, therefore more osteoclast stimulation. The
OPG concentrations decreased steadily over time through the duration of the
experiment. OPG levels were highest at baseline, and they did not begin to return to
baseline following force removal. OPG’s behavior seen in this study is to be expected,
since the mechanical force delivered by the spring encourages bony remodeling (Figure
53).
The findings in this study for RANKL concentration over time are contradictory
to previous studies. Brooks et al. (2009) reported that increases in RANKL can be seen as
early as 24 hours following a constant orthodontic force. According to Li et al. (2011),
heavier forces produce concentrations of RANKL over an extended period of time when
compared to a light force. Reports by Kim et al. (2007) stated that PDL cells are
constantly producing RANKL during continuous orthodontic force. However, there
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were not an excessive number of osteoclasts produced. On the other hand, the
decreased levels of OPG after force application seen in this study are supported by
several prior studies. Toygar et al. (2008) reported OPG concentration decrease in a
time‐dependent manner from baseline, and he concluded that OPG is one of the key
mediators in alveolar bone remodeling during orthodontic tooth movement. In 2006,
Nishijima et al. demonstrated that OPG levels were significantly decreased, while
RANKL levels were significantly increased at 24 hours after force application.
The departure of RANKL concentrations from the expected pattern could be
explained by the specificity of the ELISA assay used for this experiment. The assay
utilized in this study only detects the soluble isoform of RANKL. Also, the system used
was cell‐free; as a result, no cell‐bound RANKL was available to be detected. Therefore,
if the majority of the RANKL produced during orthodontic force is one of the
transmembrane isotypes, our assay would not have the capability of detecting it. As
technology advances, the assay kits will most likely become more sensitive to detecting
these biomolecules in their different isoforms. In addition, our analysis of RANKL was
purely extracted from human gingival crevicular fluid without using invasive measures.
RANKL and OPG can also be made by PDL fibroblasts, gingival fibroblasts, and
lymphocytes. Therefore, it is possible that substantial amounts of RANKL reside in the
PDL tissues and not the crevicular fluid itself. To date, most studies involving
orthodontic forces and the production of RANKL and OPG involve rats, beagles, and the
extracted human premolar teeth. In these studies, the PDL tissue can be examined more
closely under immunofluorescence or histologically. By merely looking at the
collections of gingival crevicular fluid, this study was limited to the expression of
RANKL and OPG found freely moving about the gingival sulcus.

RANKL: Sources of Variation
When evaluating the RANKL in regards to sex, the literature falls short.
Currently, there is no published study that discusses the levels of RANKL in males
versus females in regards to orthodontic tooth movement. The results of the present
study suggest that there is no significant difference in RANKL between men and women
undergoing orthodontic tooth movement. However, males consistently had greater
levels of RANKL than females at each examination time (Figure 36).
Kawasaki et al. (2006) showed that the degree of tooth movement is greater in
children than in adults when exposed to the same amount and duration of orthodontic
force. Hence, one might conclude that children have a higher level of RANKL in their
crevicular fluid, while adults have a lower level of RANKL in their crevicular fluid. For
RANKL, the results of our study contradict those findings. This study revealed that
there is no difference in RANKL expression between adults and adolescence when
exposed to a mechanical orthodontic force (Figure 43).
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RANKL levels were also evaluated in American whites and African Americans.
This aspect of the study was added due to sampling convenience in the patient
population. No other studies can be found which evaluates RANKL levels between the
two populations. For this study, no significant difference was found between the two
races in RANKL levels.

OPG: Sources of Variation
From an in depth review of the literature, there appears to be no studies
published on sex difference in the levels of OPG during orthodontic force application.
The results of our study show a significantly higher amount of OPG in males at all five
time points. The source of the significance between the sexes is two‐fold: 1) females had
an increased level of RANKL at T5, and 2) males had an increased level of OPG at
baseline. The difference in the baseline measurements between males versus females is
an interesting finding. It appears that women have less OPG in general, which might
explain why women are more susceptible to osteoporosis than their male counterparts
(Figure 37).
As mentioned, Kawasaki et al. (2006) reported that adults have less clinical tooth
movement than adolescence, so it can be surmised that adults have more OPG than
children. The present study showed that adults have less OPG than their younger
counterparts. The decrease in OPG levels appears to be linear with age, though there is
a lot of inter‐individual variability (Figure 49). It is possible that the younger subjects
had increased amounts of OPG due to the constant bony deposition associated with
growth. However, if normal growth and development causes an increase in OPG levels
in a growing child, then one must also assume that RANKL levels should be increased
as well, which is not the case. A future study might shed light on the individual changes
in the RANKL/OPG ratio differences between adults and children over time in response
to a mechanical force.
This study was the first to look at OPG concentrations between American whites
and African Americans in response to an orthodontic force. The data did not produce a
significant difference in OPG levels between the races, however the OPG concentrations
of the blacks were found to be higher at each examination than the whites (Figure 52). A
larger, more homogenous sample might produce a significant difference. Clinically,
tooth movement in African Americans is more difficult to achieve than in whites,
especially with increased age. The higher levels of OPG found in blacks in this study
might partially explain the increased difficulty of tooth movement in this race.
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The RANKL/OPG Ratio
The RANKL/OPG ratio describes the relative state of the body’s bony
metabolism. This ratio expresses the existing state of the bone’s regulatory system,
which is controlled by the regulation of specific gene expression. The RANKL/OPG
regulatory axis serves the purpose of maintaining bone structure and function, in
addition to meeting the body’s physiological needs for ions sequestered in bone (Boyle et
al. 2003; Kanzaki et al. 2001). An increased RANKL/OPG ratio would favor osteoclast
formation and activation; as a result, bone resorption occurs. On the other hand, a
decreased RANKL/OPG ratio promotes bone formation by inhibiting osteoclastic
activity (Kanzaki et al. 2001). An increase in RANKL and a decrease in OPG during
osteoclastogenesis is reported in the literature (Kanzaki et al. 2001; Liebbrandt and
Penninger 2008). Thus, an increase in the RANKL/OPG ratio should be seen with
continuous mechanical force over time. In this study, OPG decreased with increased
duration of force; however the levels of OPG did not rebound after force removal. For
RANKL, the levels initially dropped, but then increased two days after spring
placement. After the removal of the spring, the RANKL levels returned toward baseline.
The data from this study suggest that the RANKL/OPG ratio changes little after day 2
(48 hours after spring placement), when OPG becomes less common, which in effect
increases the RANKL/OPG ratio. A future study with increased precision and better
assay sensitivity will allow a more in depth examination of the changes in the
RANKL/OPG ratio over time in response to a mechanical force. A disadvantage to this
study was the fair amount of “zeros” reported in the assays. The zero value does not
mean that RANKL or OPG was not present, but unfortunately that the levels of these
biomolecules were below the level of detectability of the assay.
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CHAPTER 6.

SUMMARY AND CONCLUSIONS

This study evaluated changes in RANKL and OPG expression in human gingival
crevicular fluid in growing (adolescent) and non‐growing (adult) patients in response to
orthodontic force. This study assessed 54 participants of various ages. Although there
were no set age groupings for this study, in order to treat age as a category, a number of
the patients were less than 16 years of age or older than 30 years. The adolescent and
adult groups were matched as best as possible for age, sex, and race. Major finding
included:














The volume of GCF expressed into the sulcus significantly increased following
application of orthodontic force and remained elevated until after the removal of
the force. This supports the theory that orthodontic tooth movement is
associated with an inflammatory‐like reaction of the periodontium in response to
mechanical force.
When comparing buccal and lingual GCF production, higher amounts of GCF
were seen in the lingual sites throughout the duration of the study.
GCF expression exhibits high inter‐individual variability.
There was no statistically significantly differences found in the levels of GCF
when comparing age, sex, and race; however, some of the findings were highly
suggestive:
o Adult participants showed a higher mean amount of GCF at all time
points when compared to the adolescent group for the lingual collection
sites.
o Females had higher levels of GCF collected from their lingual sites, while
males, on the contrary, had higher levels of GCF collected from their
buccal sites.
o The amount of GCF collected from both Caucasians and African
Americans were nearly identical, and therefore not statistically
significant.
When evaluating the changes in gingival crevicular fluid in response to
mechanical force, it appears that time is the significant factor regardless of the
person’s age, sex, or race.
The identification of RANKL and OPG were identified in the majority of the
samples; however, there were still many instances in which the levels of RANKL
and/or OPG were below the level of detectability for the sensitivity of the assays
that were used.
Whereas RANKL and OPG are readily detectable in GCF obtained from patients
with periodontitis, these cytokines appear to be expressed in smaller amounts in
response to orthodontic force.
RANKL concentrations decreased significantly over the time the spring was in
place.
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The OPG concentrations decreased steadily over time through the duration of
the experiment.
The RANKL/OPG ratio increased over time, which favors osteoclast activation
and formation leading to bone resorption.
No significant differences were found in the levels of RANKL when comparing
sex, age, and race. However, males consistently had greater levels of RANKL
than females at each examination time.
Significantly higher levels of OPG were found in males throughout the duration
of the study.
Adults have less OPG than their younger counterparts. The decrease in OPG
levels appears to be linear with age, though there is a lot of inter‐individual
variability.
The OPG concentrations of the African Americans were found to be higher at
each examination than the Caucasians; but it is not statistically significant.
RANKL and OPG may be present in greater levels in the tissues surrounding the
teeth. The levels present in the GCF may not be representative of what is
occurring in the tissues during orthodontic tooth movement.
Further research is needed using more sensitive methods to better describe the
changes in RANKL and OPG in response to orthodontic force, and what effects
these molecules have on orthodontic tooth movement.
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